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The central aim of modern embryology is the resolution of the
signaling pathways and transcriptional networks that direct embryonic
development. After a century of rich experimental embryology, more
recent molecular analyses of embryogenesis have revealed that
communication between cells drives some of the most important events of
development, including cell fate determination, growth, and
morphogenesis. Among signaling factors, the TGF-β superfamily regulates
all of these phenomena, and is the focus of this work. Despite significant
progress in understanding the role of individual TGF-β ligands, their
ultimate integration as a pathway is not fully understood and several
ligands remain unexplored.
In this work, I present the first comprehensive, comparative
analysis of a mammalian-specific, structurally atypical TGF-β ligand, GDF3. This work was first motivated by the finding that GDF-3 is strongly
associated with the pluripotent state, and is one of the earliest ligands
expressed in the mammalian embryo. However, nothing was previously

known about its function in stem cells, or in normal embryonic
development.
Using frog embryos, mouse embryos, and mouse and human
embryonic stem cells, I found that GDF-3 is a BMP-inhibitory ligand,
adding to its unusual properties and extending the variety of regulatory
strategies governing the TGF-β pathway. This inhibitory function endows
GDF-3 with multiple activities, including the ability to directly induce neural
tissue in frog embryos, thus highlighting the evolutionary conservation of
mechanisms for neural formation. In mammalian embryonic stem cells, we
found that GDF-3 opposes BMPs to regulate the balance of stemness and
differentiation. These findings reveal the importance of negative, inhibitory
information in the determination of the earliest embryonic cell fates.
Further, I found that GDF-3 is required for normal patterning of the
mouse embryo; its reduction causes a dramatic and unprecedented
phenotype. In genetrap GDF-3 mutants, disorganized, distal migration of
the notochord results in dorso-ventral rearrangment of the entire embryo.
This finding provides a genetic basis for dissecting the tightly coupled
processes of morphogenesis and cell fate determination in the mammalian
embryo.

This work establishes a clearer picture of the pleitropic TGF-β
superfamily and contributes to an understanding of the conserved
molecular basis of embryonic development.
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This work is dedicated to my son, Max, whose inquisitiveness reminds me to
always ask “Why”
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CHAPTER 1: BACKGROUND

In metazoans, the union of sperm and egg, two highly differentiated cell
types, gives rise to the zygote – the totipotent cell. The zygote has the potential
to form every cell type of the embryo and the adult organism through a series of
sequential cell fate decisions that successively limit its range of potency. For
example, the cells of the very early mammalian embryo divide, maintaining their
totipotency until they reach sixteen to thirty-two cells, at which point outer cells
will give rise to extra-embryonic tissues, such as the placenta, and inner cells
are fated to give rise to the embryo proper (Pedersen et al., 1986; Ziomek and
Johnson, 1982). This, the choice between the outer trophoblast and the ‘inner
cell mass’, represents the first recognized restriction in cell fate potential.
The development of the embryo then follows from the establishment of
the major axes: head versus tail (anterior-posterior axis), front versus back
(dorsal-ventral axis), and the left-right axis. These coordinates are not merely
geometric but are associated with the development of specific patterns of cell
fate. Within this context, the germ layers form - ectoderm, mesoderm, and
endoderm – and progressively differentiate into the various tissues of the final
organism. These cell fate decisions occur as the result of communication
between cells.
The extrinsic information that cells receive must be transferred into
intrinsic cellular responses at the protein and transcriptional levels, a process
1

known as signal transduction (Brivanlou and Darnell, 2002). Several interconnected signal transduction pathways have been identified and these play
critical roles in both development and disease. These pathways involve an extracellular protein signal that binds to a receptor on the surface of the target cell.
Upon binding this protein ‘ligand’, the receptors initiate a cascade of rapid,
amplified reactions that send intracellular transducers to mediate the cellular
response. Most commonly, these responses impinge on other signal
transduction pathways and, ultimately, on target gene transcription levels in the
nucleus. This ‘locks down’ the flexible extrinsic signal into a stable, cell
autonomous response.

1.1 - TGF-β Signal Transduction in Embryogenesis
In development and adulthood, one of the most important signal
transduction pathways is the Transforming Growth Factor-β (TGF-β) pathway.
This pathway has a primary role in the formation of each of the germ layers of
the early embryo: ectoderm, mesoderm, endoderm, and of germ cells (Conlon et
al., 1994; Hemmati-Brivanlou et al., 1994; Hemmati-Brivanlou and Melton, 1992;
Hemmati-Brivanlou and Melton, 1994; Hemmati-Brivanlou et al., 1992; Lawson
et al., 1999; Smith, 1987; Sokol et al., 1990; Thomsen et al., 1990).
Concurrently, TGF-β signaling helps to establish all three axes of polarity in the
organism (the anterior-posterior axis, the dorsal-ventral axis, and the left-right
axis) (Ariizumi et al., 1991; Harland, 2004; Levin et al., 1995; Perea-Gomez et
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al., 2002; Robertson et al., 2003; Varlet et al., 1997; Vonica and Brivanlou, 2007;
Wilson et al., 1997; Yost, 2001). Later in development, this pathway has diverse
effects on cell fate, cell shape, and organ formation in many of the various
tissues of the organism. TGF-β signaling has pleiotropic effects on many cell
types and, not surprisingly, there are many different TGF-β ligands, several
signal transducers, and a very large variety of TGF-β target genes. In the
mammalian genome, there are approximately 40 TGF-β ligands (Lander et al.,
2001). The basic features of a TGF-β ligand are a secretion signal, and a prepro
domain that is cleaved to form the mature form that has a cysteine knot protein
structure. The TGF-β ligands are divided roughly by homology into two major
branches, the BMP/GDF (Bone Morphogenetic Protein/Growth and
Differentiation Factor) branch and the TGF-β/Activin/Nodal branch. A
classification of TGF-β ligands, based on the cysteine knot structural backbone,
is shown in Figure 1.
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Figure 1: The TGF-β superfamily ligands, classified by cysteine arrangment of
the mature domain. The prepro region of the ligands (green) is cleaved from the
mature region (red). The mature region contains cysteines (numbered from –1
through 7) that characterize the different subfamilies of TGF-β ligands. Type 1
ligands, the Activins and classic TGF-β ligands, contain the seven canonical
cysteines (1-7) in addition to two additional cysteines. Type 2 ligands contain
the seven canonical cysteines (1-7) and represents the BMP/GDF subfamily of
ligands. Type 3 contains cysteines 1-6 and only represents one ligand, Xnr3.
Type 4 ligands are missing the 4th canonical cysteine, the one involved for
intermolecular interactions. From Levine and Brivanlou, 2006a.
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Figure 1
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TGF-β ligands are secreted as dimers and bind to a two-part receptor on
the surface of the target cell that is made by the association of a two Type 1 and
two Type 2 TGF-β receptors (Shi and Massague, 2003). The classic TGF-β
ligands, together with Activin, Nodal, and related ligands (including GDF1), are
grouped together. The activating ligands of this group bind the Type 1 receptors
Alk4, Alk5, and Alk7 and activate the pathway through C-terminal
phosphorylation of the signal transducers Smad2 and Smad3. These Smads
then bind to a common transcriptional co-regulator, enter the nucleus, and
activate transcription of target genes, together with other transcriptional coregulators, such as Smad4 (Figure 2). The other major branch of the TGF-β
family includes BMP and most GDF ligands. The activating ligands of this group
bind the Type 1 receptors Alk2, Alk3, and Alk6 and activate Smad1, Smad5, and
Smad8 that regulate transcription together with a common co-regulator and
another co-regulator such as OAZ (Figure 2) (Shi and Massague, 2003).
However, some GDF ligands, for instance GDF-1, signal through the Smad2/3
branch of the pathway (Wall et al., 2000).
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Figure 2

Figure 2: A simplified version of the TGF-β superfamily signaling pathways. The
TGF-β ligands are divided into two families, the TGF-β/Activin/Nodal ligands on
the right, and the BMP/GDF ligands on the left. The classic ligands bind to a
heterodimeric receptor and activate Smads in the cell to regulate transcription.
Smad1, Smad2, and Smad4 are shown as representative of the Smad1,5,8
subgroup, the Smad2,3 subgroup, and the Smad4a, 4b subgroups, respectively.
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While the above abstract summary of a signal transduction pathway
describes a linear path from extra-cellular signal to nuclear response, it is
becoming clear that the TGF-β pathway is much more complex. One of the most
important complex characteristics is the ability of TGF-β ligands to act as
morphogens (Ariizumi et al., 1991; Green and Smith, 1990; Vincent et al., 2003;
Wilson et al., 1997). This means that at different thresholds of signal transducer
activation, TGF-β signaling can elicit different effects on the target cell, within a
given window of time.
Another major feature of TGF-β signaling is that there are several
mechanisms of Smad-independent signal transduction, for instance, through
Tak/TAB (TGF-β Activated Kinase 1/Tak1 Binding Protein 1) signaling onto the
MAPK pathway (Munoz-Sanjuan et al., 2002; Shibuya et al., 1996; Yamaguchi
et al., 1995). Interestingly, some divergent TGF-β family members may not
signal through Smads at all. For instance, GDNF and similar ligands signal
through the Ret receptor to activate tyrosine kinases (Durbec et al., 1996; Jing et
al., 1996; Trupp et al., 1996). Further complexities of TGF-β pathway signaling
include the following: each ligand, receptor, signal transducer, and effector are
regulated spatially and temporally within the embryo; similar ligands can have
different strengths of activity (Aono et al., 1995); some ligands require coreceptors while others do not (Gritsman et al., 1999); related signal transducers
may bind co-regulators with different affinities (Hata et al., 1998); and the
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ongoing signaling status of other signal transduction pathways co-regulate all
levels of the TGF-β pathway.
1.2 TGF-β signaling in early embryos: lessons from the frog
Many of the fundamental findings on the embryonic roles of this pathway
were first characterized in the frog embryo, where TGF-β signaling has been
shown to play a role in the development of every germ layer and most tissues
analyzed. TGF-β ligands were first found to be regulators of cell fate in early
embryos when Activin was identified as a mesoderm inducer in Xenopus cells
and embryos (Smith, 1987; Thomsen et al., 1990). It was subsequently found to
act as a morphogen, inducing distinct cell fates at different doses (Ariizumi et al.,
1991; Green et al., 1992; Green and Smith, 1990). Low doses induce posterolateral mesoderm, intermediate doses induce dorsal mesoderm, and high doses
induce endoderm. In vivo, the Nodal-related ligands, Xnrs, probably account for
the Activin-like mesoderm activity as a Nodal inhibitor abrogates mesoderm
induction and the Xnrs are expressed in dorsal endoderm – precisely the
predicted location to account for the cell fate gradient readout (Agius et al.,
2000; Takahashi et al., 2000).
BMP signaling acts similarly in the ectoderm, inducing epidermis at high
doses, placodes/cement gland at intermediate doses, and in the absence of
BMP signaling, neural tissue is formed (Wilson and Hemmati-Brivanlou, 1995;
Wilson et al., 1997). This latter phenomenon provides the mechanistic basis for
the ‘neural default’ model (Hemmati-Brivanlou et al., 1994; Hemmati-Brivanlou
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and Melton, 1992; Hemmati-Brivanlou and Melton, 1994; Hemmati-Brivanlou et
al., 1992; Munoz-Sanjuan and Brivanlou, 2002). This model was based on two
linked initial observations, both of which were conducted in the animal cap
region of the frog embryo (Figure 3). This region is the prospective anterior end
of the embryo and is fated to give rise to ectoderm. When explanted and
cultured alone, the animal cap forms epidermis. However, if the cells of the
animal cap are dispersed, thereby inhibiting cell-cell communication, these cells
become neural tissue – this is the first important observation that led to the
neural default model (Grunz and Tacke, 1989). The second observation was that
over-expression of a truncated TGF-β type II receptor (that functions as a
dominant negative receptor by forming inactive receptor heterodimers) in the
animal cap gives rise to neural tissue (Hemmati-Brivanlou and Melton, 1992;
Hemmati-Brivanlou and Melton, 1994). Together, these two findings suggested
that a TGF-β related signal was normally signaling to cells of the animal cap to
inhibit differentiation to neural tissue. It was found that this factor is BMP
signaling, as exogenous BMPs can convert dispersed animal cap cells back into
epidermis (Wilson and Hemmati-Brivanlou, 1995).
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Figure 3

Figure 3: The experimental basis of the ‘neural default’ model. The animal cap
of a blastula stage frog will give rise to ectoderm (blue) at gastrula stages. If the
animal cap is isolated and cultured alone, it will give rise to epidermis. If the frog
embryo was previously injected with a dominant-negative type II TGF-β receptor
(DN ActRIIB), this tissue becomes neural. Conversion of the animal cap from
epidermal to neural fates can also be accomplished by dispersion of the cells to
prevent cell-cell signaling, a phenomenon that can be reversed by culture of the
cells with BMP proteins. The future dorsal mesoderm is shown in red, endoderm
in yellow.
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BMP inhibition is the molecular basis by which neural induction and
patterning can be ‘organized’ by a region of dorsal mesoderm. Historically, the
first experimental embryology on neural induction was done by Spemann and
his group (Spemann and Mangold, 1924). In his seminal work with Hilde
Mangold, published in 1924, they found that the dorsal blastopore lip of the
gastrulating Triturus (newt) embryo “exerts an organizing effect on its
environment in such a way that, following its transplantation to an indifferent
region of another embryo, it there causes the formation of a secondary embryo”
(Spemann and Mangold, 1924). This ‘secondary embryo’ was fused to the host
embryo at the ventral mid-line; it had two complete heads, two hearts, two of
each of the main dorsal structures (the notochord, neural tube, and somites) and
one gut tube.
Surprisingly, early lineage tracing demonstrated that while the entire axial
mesoderm (notochord) of the secondary embryo is derived from the progeny of
the graft, the nervous system (except the floorplate) was derived from the host
(Mangold, 1933). This clearly indicates a non-autonomous, extrinsic influence of
the graft on its neighboring host cells. The term ‘neural induction’ therefore
comes from an observation made in the last century that a small region of dorsal
mesoderm can initiate formation of the entire nervous system. Secreted
inhibitors of BMPs, such as Noggin and Chordin, were subsequently localized to
correspond spatio-temporally with the functional organizer, as defined by
Spemann and Mangold to be the source of neural inducing signals. This tissue
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then gives rise to the notochord, accounting for the graft-based origin of this
tissue in the secondary embryo.
In addition to regulating cell fate in the ectoderm, BMP signaling helps to
establish the dorso-ventral arrangement of cell fates within the mesoderm. Overexpression of BMP4 in the mesoderm causes extreme ventralization (Dale et al.,
1992; Jones et al., 1992a), while over-expression of BMP inhibitors is sufficient
to induce dorsal mesoderm (Smith and Harland, 1992). In between these
extremes, increasing doses of classic BMPs progressively pattern notochord,
muscle, kidney, and, at the highest doses, blood (Dosch et al., 1997; HemmatiBrivanlou and Thomsen, 1995).
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Figure 4: Spemann’s organizer and neural induction by BMP inhibition in frog
embryos. (A) A gastrula stage frog (stage 10+) is shown, detailing the location of
critical signaling factors that induce neural tissue in vivo. In the frog embryo,
BMP signaling is active in the ventral (yellow) part of the embryo. This is limited
by BMP inhibitors in the dorsal organizer (maroon) and allows neural formation
in the dorsal animal region (blue). Explantation and transfer of the organizer to a
host embryo (B), results in formation of a ‘secondary embryo’ (C), in which the
double neural plate is pseudocolored in blue. A cross section of the primary and
secondary embryo (D), shows the two notochords (maroon), and two neural
tubes (blue). The single endoderm is shown in yellow. The secondary structures
are on the right in (D). (C,D) are from Figure 7 and Figure 23, respectively, of
Spemann and Mangold, 1924.
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Figure 4
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1.3 - TGF-β signaling in early embryos: conserved roles in the mouse
Many of the findings regarding TGF-β signaling in the frog embryo were
confirmed and extended using genetic loss-of-function analysis in mouse
embryos, particularly the classic examples of Activin/Nodal signals in mesoderm
formation and inhibition of BMP signaling in neural induction. For instance, the
mouse mutant of Nodal fails to form mesoderm and dies at peri-gastrulation
stages (Conlon et al., 1994). Reduction of Nodal signaling through partial loss of
its signal transducers, its transcriptional targets, or through a hypomorphic Nodal
allele reveal that the highest levels of Nodal signaling in the embryo proper are
required to induce anterior definitive endoderm and anterior axial mesoderm
(Lowe et al., 2001; Vincent et al., 2003; Yamamoto et al., 2001). This was
predicted from the morphogen gradient experiments in frog embryos, showing
that the highest doses of Activin induce dorsal endoderm and notochord
(Ariizumi et al., 1991; Green et al., 1992; Green and Smith, 1990).
In mouse development, the molecular and tissue basis of neural inducing
signals have not been determined, though new evidence suggests an important
conserved role for BMP inhibition, together with Nodal inhibition, in establishing
the neural tissue. Importantly, recent work found that loss of the BMP receptor
Alk3 (Di-Gregorio et al., 2007) or of Nodal (Camus et al., 2006) each result in a
dramatic and precocious conversion of almost the entire epiblast into anterior
neural tissue that expresses Otx2 and Sox1 as well as markers of anterior
forebrain such as Six3, Dlx5, and Hesx1. Thus, it seems that, normally, Nodal
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and BMP signaling are required during pre-gastrulation stages to prevent a
default acquisition of neural fate and to maintain a pluripotent epiblast that also
can form epidermis, mesoderm, and endoderm.
While the molecular mechanism of BMP inhibition is conserved in the
mouse as the primary mode of neural induction, the identity of the tissues that
mediate these signals are not clearly understood (Levine and Brivanlou, 2007).
Briefly, neural tissue is first specified in the distal epiblast by mid streak stages,
by signals emanating from the organizer (Figure 5). More posterior neural tissue
is induced by the node, which has full organizer-like properties and the ability to
induce an ectopic secondary axis upon transplantation. Subsequently, the node
gives rise to the notochord, which serves as an organizing center for axial
structures and plays a role in patterning the neural tube, foregut, and paraxial
mesoderm. Therefore, as in the frog, the organizer and its derivatives direct the
ongoing formation of the neural tube and dorsal axis.

17

Figure 5

Figure 5: Neural induction in mouse embryos. At approximately e7.0 (mid-streak
stage), the gastrula organizer (maroon), possibly in cooperation with the anterior
visceral endoderm (AVE, green) allow neural induction to occur in the anterior
epiblast (blue). This involves limiting BMP signaling (yellow) to the
posterior/proximal embryo and may also involve regulation of other pathways
such as Nodal and FGF.
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1.4 TGF-β signaling in embryonic stem cells
To study new layers and functions of this complex pathway in early
embryonic cell fate determination, I analyzed the TGF-β pathway in embryonic
stem cells – an in vitro system in which differentiation recapitulates many of the
early steps of normal embryogenesis. Embryonic stem cells are derived from the
inner cell mass of the blastocyst and can self-renew in the undifferentiated state
and can differentiate into all of the cell types of the embryo proper (reviewed in
(Brivanlou et al., 2003). This latter characteristic allows a rapid analysis of
factors involved in cell fate determination. More importantly, embryonic stem
cells provide an opportunity to extend analysis of differentiation to a human
embryological system.
Together with my colleagues, I found that Activin/Nodal signaling is active
in early mouse embryos and in both mouse and human embryonic stem cells, as
revealed by phosphorylation and nuclear localization of Smad2/3 (James et al.,
2005). This activation is significant for the pluripotent state as exogenous Activin
or Nodal promote pluripotency in human embryonic stem cells (Beattie et al.,
2005; James et al., 2005; Vallier et al., 2004). Further, Activin/Nodal signaling is
required for the maintenance of stemness in human embryonic stem cells
(James et al., 2005; Vallier et al., 2005). While inhibition of Alk4/5/7 signaling in
mouse embryonic stem cells does not affect pluripotency (Dunn et al., 2004;
James et al., 2005; Vallier et al., 2005), blocking Nodal signaling in blastocyst
outgrowths severely reduces levels of the inner cell mass and stem cell marker,
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Oct4 (James et al., 2005). These findings show that Activin/Nodal signaling is
important for pluripotency in human embryonic stem cells, mouse embryos, and
mouse epiblast stem cells, although it is unclear why mouse embryonic stem
cells do not require activation of this pathway.
In contrast to Activin/Nodal signaling, the role of BMP signaling in
embryonic stem cells is somewhat controversial. In human embryonic stem
cells, BMPs promote rapid differentiation to extra-embryonic cell fates even
when these cells are cultured in feeder conditioned media that normally
maintains their pluripotent state (Xu et al., 2002), despite the facts that stem
cells express both the BMP inhibitor GDF-3 and the inhibitor Lefty (Sato et al.,
2003) and that feeder cells secrete a BMP inhibitor as well (Xu et al., 2005).
Further, human embryonic stem cells can be maintained without conditioned
media by an exogenous combination of FGF activation and BMP inhibition (Xu
et al., 2005). These findings suggest that the normal inhibition of BMP signaling
in stem cells and early embryos is required to suppress differentiation to extraembryonic fates.
In mouse embryonic stem cells, BMP signaling through Smad1/5/8 is
normally minimally activated. However, moderate levels of exogenous activation
of the BMP pathway may cooperate with other stemness pathways to support
the undifferentiated state (Levine and Brivanlou, 2006b). However, as BMPs are
morphogens (Wilson et al., 1997), it is possible that low levels of BMP signaling
support pluripotency while higher levels push the cells to differentiate. This role
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of BMPs is supported by in vivo evidence showing that reduced BMP signaling
(in the BMPR1A knockout) results in loss of epiblast markers Oct4 and FGF5 at
pre-gastrula stages (Di-Gregorio et al., 2007).

1.5 - GDF-3 is a TGF-β family member associated with stemness
After contributing to a broad analysis of the roles of TGF-β/Activin/Nodal
signaling in embryonic stem cells, I chose to focus on specific ligands. A rich
literature has shown that there can be subtle and dramatic functional differences
between ligands, even those that are closely related. While many TGF-β
superfamily members have well characterized functions in development and
disease, several remain unexplored.
I studied a comparison of genes expressed in cells maintained in the
undifferentiated state with genes expressed in their differentiated progeny (Sato
et al., 2003), and focused my analysis on genes related to TGF-β signaling.
Interestingly, three TGF-β ligands were enriched in the undifferentiated,
‘stemness’ population and displayed a sharp decline in expression when cells
were pushed towards differentiation: Nodal, its antagonist ligand Lefty, and the
relatively unstudied TGF-β ligand GDF-3 (Sato et al., 2003; Zeng et al., 2004). In
fact, GDF-3 has become one of the most reliable markers of stemness
(Adewumi et al., 2007), although almost nothing is known about its mechanism
of action and its normal roles in stem cells and embryogenesis.
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In this work, I address the role of GDF-3 in regulating diverse processes
in early vertebrate development. To this end, I first characterized the
biochemical mechanism of GDF-3, revealing that, surprisingly, it is a BMP
inhibitor. I next sought to understand the functions of GDF-3 in each of its
primary endogenous contexts of early development and began by analyzing its
expression pattern in early embryogenesis, where it was found in the inner cell
mass of the blastocyst (and its corollary, embryonic stem cells), and in the node
and notochord. I found that GDF-3 is an endogenous BMP inhibitor in embryonic
stem cells, and that it acts in a species-specific manner to regulate the
undifferentiated state and the capacity for differentiation in human and mouse
embryonic stem cells, respectively. To analyze the role of GDF-3 in the node
and notochord, I studied a genetrap mutation of the GDF-3 locus, and found that
in 42% of embryos, GDF-3 is required for correct dorsal-ventral arrangement of
the body plan. Mutant embryos display a notochord at the ventral extreme of the
embryo and a neural tube that opens into the body cavity of the embryo, with
heart and endoderm at the extreme dorsal side of the embryo – the opposite of
their position in normal embryos. This unusual phenotype is the result of
perturbed migration of the notochord, a structure that organizes the axial tissues.
This highlights the conserved role of BMP inhibitors and the node in embryonic
patterning and reveals a requirement for normal BMP/GDF regulation in the
chemotaxis of this structure, independent of its classic regulation of cell fates. In
summary, this work provides the first comprehensive analysis of GDF-3, and
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thereby illuminates novel aspects of TGF-β superfamily regulation, mechanisms
of stemness, and basic strategies of early embryonic patterning.
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CHAPTER 2: MECHANISM OF GDF-3 FUNCTION

2.1 GDF-3 is an atypical TGF-β ligand
GDF-3 is a TGF-β superfamily member sub-classified into the BMP/GDF
(Bone Morphogenetic Protein/Growth and Differentiation Factor) branch of this
family, based on homology (Jones et al., 1992b). Of note, GDF-3 is an atypical
ligand, that has only six of the classical seven cysteines present in other TGF-β
superfamily members (Jones et al., 1992b). It is missing the fourth cysteine – the
one involved in inter-molecular interactions amongst TGF-β family members and
with their secreted inhibitors (Figure 6) (Groppe et al., 2002).
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Figure 6

Figure 6: Primary structure of GDF-3 protein. GDF-3, like all other TGF-β
ligands, contains a prepro domain and a mature domain. This mature domain
(sequence shown) is atypical, containing only six of the canonical seven
cysteines found in the cysteine knot structure of nearly all other TGF-β ligands
(plus an additional, non-canonical cysteine). All cysteines are shown in white
and the ‘missing’ fourth cysteine of GDF-3 is shown in blue. The sequence of
BMP4 is shown for comparison.
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I performed electronic library searches for homologues of GDF-3 in nonmammalian species such as Danio rerio and Xenopus laevis. However, the
putative homologues given by Ensemble all possess the seven canonical
cysteines characteristic of most TGF-β family members instead of the six
present in GDF-3, suggesting that they are not true homologues.
More importantly, these putative ‘homologues’, such as xVg1, are not
syntenic with GDF-3, but instead correspond to GDF-1. For instance, human
GDF-3 is on chromosome 12p and is flanked by ApoBec1 and Stella, genes that
are not found in the chick or in Xenopus tropicalis. Xenopus tropicalis Vg1
(CAJ82217, peptide Tegg005K01.1) is next to the genes COPE, Ddx49, then
Homer3, the precise arrangement of genes neighboring human GDF-1 on
chromosone 19.
I also designed several sets of degenerate primers based on mouse
GDF-3 sequence and screened pools of frog cDNAs but did not find any
Xenopus homologs (data not shown). Therefore, I tentatively conclude that
GDF-3 is a recent evolutionary addition, present only in mammals.
The above analysis of the GDF-3 genomic region highlights another
unusual characteristic of GDF-3. In humans, GDF-3 is located at 12p13, a region
that strongly enriched for genes associated with pluripotency, including Nanog
and Stella, which are immediately 5’ of GDF-3. 12p13 is over-expressed in 80%
of male germ cell tumors (Rodriguez et al., 2003), and down-regulation of the
genes at this locus is associated with in vivo differentiation of these tumors
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(Korkola et al., 2006). In these tumors, GDF-3 is specifically over-expressed
(Korkola et al., 2006; Skotheim et al., 2006).
I began my analysis of GDF-3 by studying its activity and biochemical
mechanism, so that I could interpret the function of GDF-3 in the results of gain
and loss-of-function experiments that were performed in parallel. I chose to
characterize GDF-3 activity in an unbiased way in the frog embryo because the
effects of TGF-β pathway signaling in Xenopus are well established through
phenotype and marker gene expression analysis. I reasoned that if GDF-3 is an
agonist or antagonist of this pathway, or even of another pathway, its function
might be partially determined through its effect on normal frog embryogenesis.
Working with a mouse gene in a frog context provided the additional advantage
that there is no ‘background’ GDF-3.

2.2 - GDF-3 elicits secondary axis induction in the frog embryo
I microinjected capped GDF-3 mRNA into the frog embryo. Unexpectedly,
I found that injection of mGDF-3 mRNA in the ventral marginal zone of the four
cell embryo, induces secondary axis formation (Figure 7A). In six batches of
embryos (n = 151), I found this phenotype in 61% of embryos. Secondary axis
induction of this type can occur by two mechanisms: induction of the Smad2/3
pathway by Nodal/Activin signaling (Thomsen et al., 1990), or inhibition of
ongoing BMP signals (Smith and Harland, 1992; Suzuki et al., 1994). In contrast,
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classic BMP/GDF ligands cause ventralization of the embryo, rather than a
second dorsal axis (Dale et al., 1992; Jones et al., 1992a).

2.3 - GDF-3 inhibits BMP-induced cell fates and BMP-induced transcription
To determine which of these mechanisms is used by GDF-3, I performed
a cell fate assay in the animal cap region of the frog embryo. As summarized in
Figure 3, this tissue forms epidermis when isolated and cultured, due to ongoing
BMP signaling. However, inhibition of this pathway activation can convert the
animal cap into neural tissue. In contrast, Activin/Nodal signaling induces
mesoderm in the animal cap, consistent with the role of these factors in the
whole embryo.
Two cell embryos were microinjected in the animal pole with mRNA
encoding mGDF-3 and allowed to develop to blastula stages. Animal caps were
isolated and cultured to either late gastrula (stage 11.5) or late neurula (stage
21). The explants were then harvested and analyzed by RT-PCR for the
detection of cell type specific markers. My analysis of expression of early and
late markers shows that in contrast to other BMP family members, GDF-3 acts
as a direct neural inducer. GDF-3 decreased expression of an immediate early
response gene to BMP signaling, Msx-1, and increased expression of both early
(Sox2) and late (Otx2 and NCAM) neural markers (Figure 7B,C). This
conversion was direct because it was not concomitant with mesoderm induction,
as demonstrated by the lack of induction of the pan-mesodermal marker
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Brachyury (BU), the ventral marker Wnt8, and the marker of axial mesoderm
collagen type II. These data demonstrated that over-expression of GDF-3 can
block BMP-induced cell fates.

29

Figure 7: Activity of GDF-3 over-expression in frog embryos. (A) 1.5-3 ng GDF-3
RNA was injected into two out four cells of frog embryos in the future region of
the ventral marginal zone and embryos were cultured until stage 32 (left panel)
or stage 41 (right panel). Control uninjected sibling embryos are shown beneath
an injected embryo in each panel. Scale bar is 1 mm. (B,C) RT-PCR of animal
caps uninjected or injected with 1 ng of GDF-3 RNA collected at stage 12.5 (left
panel) or stage 21 (right panel) to analyze early and late neural markers. Msx1 is
an epidermal marker; Sox2 is an early neural marker; Otx2 and NCAM are late
neural markers; BU, Wnt8, and Collagen type II (Coll II) are mesodermal
markers. ODC is shown as a loading control. Whole embryos with and without
reverse transcription (‘E’ and ‘no RT’, respectively) are shown as positive and
negative controls for each RT-PCR marker. (D) Luciferase assay, in arbitrary
units, from a BMP-respnsive element driving a luciferase reporter. Two cell frog
embryos were injected with reporter alone (first column), BMP4 alone (100 pg
RNA, second column), BMP4 (100 pg) and GDF-3 (500 pg) RNA (third column)
or GDF-3 RNA (500 pg) alone. Whole embryos were harvested at stage 11 and
assayed for luciferase activity.
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Figure 7
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To confirm that GDF-3 can inhibit BMP signaling, I analyzed the effect of
GDF-3 over-expression on the ability of BMP to activate a reporter gene via
Smad1/5/8. I injected two cell frog embryos with a BMP-responsive element
driving a luciferase reporter (BRE-Lux), together with RNAs for BMP4 and GDF3. Although BMP4 alone gave strong activation of the reporter gene, this
signaling was almost completely inhibited by the presence of GDF-3 (Figure 7D).

2.4 - GDF-3 mature protein inhibits BMP-induced cell fates
The activities observed for several TGF-β ligands upon over-expression
of mRNA may not reflect true functions of the protein. Therefore, I used two
approaches to study the activities of the mature protein. In the first strategy, I
produced GDF-3 protein by microinjection of 50 ng GDF-3 mRNA into Xenopus
oocytes, followed by collection of GDF-3-containing medium after 48 hours. I
examined the oocyte lysate and the conditioned media for GDF-3 protein to
check for processing and secretion of GDF-3. In the oocyte lysate, I found both
the prepro and mature forms of GDF-3 but only the mature form is secreted into
the conditioned media (Figure 8A).
I tested the activity of GDF-3 conditioned media on two mesodermal
explants derived from the marginal zone of the frog embryo. BMPs are normally
expressed throughout the early embryo but the local secretion of BMP inhibitors
in the dorsal marginal zone (DMZ) establishes the dorsal axis in normal
Xenopus embryos; therefore, creating a second region of BMP inhibition in the
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ventral marginal zone (VMZ) results in a secondary axis. The conditioned
medium was then presented to both DMZ and VMZ and the behavior of the
explants was compared to controls. Figure 8B shows that VMZ explants
normally form a sphere in culture, whereas DMZ explants elongate due to the
formation of tissues such as muscle and notochord that undergo convergent
extension. GDF-3 protein dorsalizes VMZ tissue, creating elongation and the
appearance of anterior structures such as the cement gland. Analysis of
molecular markers by RT-PCR in these explants agrees with the conclusion that
GDF-3 has strong dorsalizing activity in the mesoderm, as GDF-3 protein
decreased the expression of the ventral mesodermal marker globin and induced
the expression of dorsal paraxial markers such as m-actin in the VMZ explants
(data not shown).
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Figure 8: GDF-3 mature protein is a BMP inhibitor. (A) Western blot of GDF-3
protein produced by injection of GDF-3 RNA into frog oocytes and collection of
oocyte lysate and conditioned medium (CM) after 48 hours. Lanes 1 and 3 show
water injected oocyte lysate and CM; lanes 2 and 4 show GDF-3 injected lysate
and CM. The upper band shows GDF-3 prepro form and the lower band shows
GDF-3 mature protein, the only form seen in the oocyte conditioned medium. (B)
Effect of diluted oocyte conditioned medium containing Activin or GDF-3 protein
on frog embryo mesodermal explants – the ventral and dorsal marginal zones
(VMZ and DMZ). Activin CM is shown as a positive control for causing VMZ
elongation. The ratio of dilution is shown beneath each label. (C) Effect of
recombinant human GDF-3 protein (rhGDF-3) on cell fate in intact and dispersed
animal caps. RT-PCR on untreated (-) or rhGDF-3 or recombinant mouse Nodal
(rmNodal) treated intact animal caps are shown in lanes 3-7 at the indicated
doses. In lanes 8-12, disassociated animal caps were untreated or treated with
recombinant human BMP4 protein (rhBMP4) and challenged with increasing
doses of rhGDF-3. Sox2 is a neural marker, Msx1 is an epidermal marker, BU is
a mesodermal marker, ODC is shown as a loading control. Whole stage 11.5
embryo, with and without reverse transcription (‘E st 11.5’ and ‘no RT’,
respectively), are shown as positive and negative controls for each marker.
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Figure 8
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However, this dorsalizing activity does not distinguish between BMP
inhibition and Nodal-like activation. Therefore, I analyzed the activity of
recombinant human GDF-3 protein (rhGDF-3) on cell fate in the frog embryo
animal caps that had been disassociated into individual cells. It has previously
been shown that this manipulation removes endogenous BMP signals and
allows the animal cap cells to adopt a default neural fate, rather than the
epidermal fate that BMPs induce (Wilson and Hemmati-Brivanlou, 1995). I then
challenged these cells with exogenous BMP protein and tested the ability of
rhGDF-3 to block the effects of this exogenous BMP signaling.
I found that, at the doses that I tested, rhGDF-3 protein did not induce
mesoderm, although mesoderm was induced by the same dose of recombinant
mouse Nodal protein (rmNodal), produced from a similar source (Figure 8C).
While untreated disassociated cells became neural, rhBMP4 reverted these cells
to epidermis. Increasing doses (0.5 - 4 ng/mL) of rhGDF-3 blocked this activity of
rhBMP4 (Figure 8C). I also tested 15 ng/mL of rhGDF-3 and found that it had the
same effect (data not shown). Therefore, at these protein doses, GDF-3 is a
BMP inhibitor and does not act like a Nodal ligand.

2.5 - GDF-3 is required endogenously for full BMP inhibition
To study the physiological role of GDF-3, I analyzed the effects of
reducing GDF-3 function in mouse embryonic stem cells. I used genetrap
embryonic stem cells carrying an interruption of the GDF-3 locus (detailed in
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Chapter 3.4). I injected these embryonic stem cells into host blastocysts to
generate a line of mice with the genetrap insertion. Using these mice, I mated
heterozygous pairs and obtained blastocysts that gave rise to wild-type,
heterozygous, and homozygous genetrap mouse embryonic stem cells.
I characterized six embryonic stem cell lines – three wild-type lines, two
heterozygous lines, and one homozygous genetrap line – and analyzed the state
of TGF-β signaling in these cells. I first analyzed the ongoing signaling levels of
the TGF-β/Activin/Nodal and BMP/GDF pathways in these cells by examining
the phosphorylation status of Smads which mediate the intracellular signal
transduction of these pathways.
I found that the heterozygous and homozygous genetrap lines, with
reduced levels of GDF-3 protein, displayed mildly increased levels of BMP
pathway activation. However, BMP signaling in embryonic stem cells is active at
extremely low levels endogenously. To further examine the effect of reduced
GDF-3 levels on BMP signaling, I stimulated the embryonic stem cells with
recombinant BMP4 protein.
I found that all of the cell lines showed dramatically increased BMP
signaling, but that this activation was most pronounced in heterozygous or
homozygous ES lines that had reduced levels of GDF-3 signaling (Figure 9).
After normalization to total Smad1 levels, quantification demonstrated that ES
lines with reduced GDF-3 levels had 1.7 +/- 0.3 times Smad1 phosphorylation,
compared with an average of three wild-type lines. There was no difference
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between heterozygous and homozygous genetrap ES lines in activation of
Smad1. There was an average increase in Smad2 phosphorylation in
heterozygous and homozygous genetrap ES lines of 1.5 +/- 0.4 times, compared
with the average of three wild-type lines. These results confirm that, in cells that
normally express GDF-3, this factor is required for normal regulation of the BMP
pathway, but does not play a role in activating the TGF-β/Activin/Nodal-like
signaling.
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Figure 9

Figure 9: GDF-3 is an endogenous BMP inhibitor. Mouse embryonic stem cells
that were wild-type (Wt), heterozygous (Ht), or homozygous (KO) for a genetrap
insertional mutation in the GDF-3 locus were analyzed for activation status of
Smad signaling. Cells were untreated (left) or treated with rhBMP4 for one hour
(right). Phosphorylation at the MH2 site of Smads1/5/8 or Smad2/3 (P-S1 or PS2) was used to assess activation of BMP signaling or Nodal signaling,
respectively. Total Smad1 (S1) and Smad2 (S2) are shown as controls. Total
levels of GDF-3 protein (full length prepro form) are shown.
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2.6 - GDF-3 inhibitory properties reside in both the prepro form and the
‘missing cysteine’
GDF-3 protein contains two elements that distinguish it from most TGF-β
family members: it is missing the fourth canonical cysteine and it is poorly
processed and, as such, is mainly in the prepro form in cells that express it
endogenously (embryonic stem cells) or exogenously (frog embryos). I
therefore sought to determine whether either of these characteristics endow
GDF-3 with its unusual activity of inhibiting its own family members. I created
two mutations in GDF-3 to pursue these experiments. The first mutation
converts the cleavage recognition sequence of GDF-3, RKRR, into the
sequence GNVG. This cleavage mutation (CM) prevents the cleavage
maturation of GDF-3 so that the protein only exists in the prepro form. The
second mutation replaces the ‘missing’ cysteine in GDF-3 by converting the
valine at this residue to a cysteine (VtoC mutation).
As a preliminary test of the function of these constructs, I injected them
into frog embryos and analyzed their ability to inhibit co-injected BMPs by
luciferase assay. As shown in Figure 10, the cleavage mutant of GDF-3 retains
the full ability to inhibit BMP signaling. To determine whether this activity
requires the mature domain at all, I also tested the prepro domain of GDF-3
alone for its ability to inhibit BMP-induction of the luciferase reporter and found
that the prepro domain is a weak BMP inhibitor.
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Figure 10: Effect of GDF-3 mutations on BMP inhibitory activity. Luciferase
activity (in arbitrary units) from a luciferase construct regulated by a BMP
responsive element (BRE-Lux) was measured on whole embryos lysed at stage
10.5 after being injected at the two cell stage. Embryos were injected with
reporter alone (first column), BMP4 RNA (green column, first lane of western
blot), or BMP4 RNA together with RNA for GDF-3 constructs. The following
constructs were tested: wild-type (Wt), cleavage mutant (CM), prepro domain
alone (prepro), ‘missing cysteine’ reverted (VtoC), and a double mutant of VtoC
and CM (VtoC/CM). Below the luciferase graph, a western blot of each lane is
indicated showing prepro and mature forms of GDF-3.
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Figure 10
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I also tested the activity of the VtoC mutant GDF-3 and observed that this
mutant is also a weak BMP inhibitor. To test whether other aspects of the GDF-3
protein have inhibitory activity, I created a double mutant with both a mutated
cleavage site and the VtoC substitution. This form of GDF-3 was only able to
slightly reduce BMP-induced transcription, indicating that both of the unusual
features of the GDF-3 protein (its predominant prepro form and missing
cysteine) provide redundant mechanisms for blocking BMPs and account for
most of the inhibitory behavior of GDF-3 (Figure 10).

2.7 - GDF-3 protein interacts physically with BMP proteins
To determine whether GDF-3 inhibition of BMPs may be direct, I
performed reciprocal co-immunoprecipitation assays and found that GDF-3 and
BMP4 protein interact. HA-tagged BMP4 (or untagged BMP4) and Flag-tagged
GDF-3 were injected into the animal pole of frog embryos at the 2 to 4 cell stage,
and embryos were cultured to gastrula stages. The animal caps were lysed and
immunoprecipitated using anti-HA or anti-Flag. Flag-GDF-3 immunoprecipitates
prepro and mature BMP4 (60 kDa and 25 kDa) and HA-BMP4
immunoprecipitates the prepro (45 kDa) and mature (20 kDa) forms of GDF-3
(Figure 11A).
I also tested whether GDF-3 interacts with other TGF-β members to
determine whether the interaction between GDF-3 and BMP4 is specific or
reflective of promiscuous binding by GDF-3. I found that GDF-3
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immunoprecipitates xVg1 and xNR1 but not Activin upon over-expression in
Xenopus animal caps (Figure 11B). Interestingly, although the prepro form is
the major form produced in cells and immunoprecipitated in these assays, the
interactions do not rely on the prepro domain. I tested this by using GDF-3 to
immunoprecipitate BMP4 containing the BMP4 pro-domain or the Activin prodomain and found that GDF-3 immunoprecipitates both forms (data not shown)
whereas it does not interact with Activin.
I sought to determine whether GDF-3 can interact with BMPs
extracellularly, providing a mechanism for its inhibition. I used COS cells that
stably express either EYFP or GDF-3-Flag and transfected with EYFP or with
mBMP4-HA. I performed immunoprecipitations on conditioned media or cell
lysate from cells that co-expressed GDF-3-Flag and BMP4-HA as a positive
control for interaction and compared these to immunoprecipitations performed
on combined conditioned media or cell lysate from cells expressing either GDF-3
or BMP4. I found that GDF-3 and BMP4 interact whether they are co-secreted
from the same cells, or expressed separately, confirming that this interaction
could take place extracellularly (Figure 11C).
In this experiment, I also tested whether co-expression of GDF-3 and
BMP4 altered the levels of production or secretion of either ligand but found no
difference between BMP4 production or secretion when BMP4 was expressed
alone or together with GDF-3, suggesting that GDF-3 does not inhibit BMPs in
the producing cell (Figure 11C).
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Figure 11: GDF-3 protein interacts physically with BMP4 protein. (A) Reciprocal
co-immunoprecipitation of Flag-tagged GDF-3 and HA-tagged BMP4 protein
produced by over-expression at the two cell stage of frog embryos, followed by
lysis and precipitation at stage 11. The top two panels show western blot (WB)
for 10% of the crude lysate for BMP4 and GDF-3. The third panel shows the
result of the immunoprecipitation with GDF-3, probed for BMP4, and the fourth
panel shows the immunoprecipitation of BMP4, probed for GDF-3. (B) GDF-3
was immunoprecipitated by BMP4-HA but not Activin-HA in an assay similar to
that in ‘A’ followed by western blot for prepro and mature GDF-3. (C)
Immunoprecipitation of GDF-3 and BMP4 in solution. GDF-3 and BMP4-HA
were produced in COS cells and the conditioned media (CM) from these cells
was immunoprecipitated with anti-HA antibodies and probes for GDF-3. In lanes
1 and 4, GDF-3 was produced alone in COS cells, in lane 2 BMP4 was
produced alone, in 3 and 5, GDF-3 and BMP4 were co-expressed in the same
cells, in lane 6 conditioned media from COS expressing either GDF-3 or BMP4
alone was mixed before immunoprecipitation. 10% of crude CM is shown in
lanes 1-3, probed by western blot for prepro GDF-3 together with prepro and
mature BMP4; immunoprecipitation is shown in lanes 4-6, probed by western
blot for prepro and mature GDF-3.
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Figure 11
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2.8 Chapter Summary
These experiments provide a foundation for understanding the
mechanism of GDF-3 activity. I used gain-of-function analysis of GDF-3 mRNA
in the frog embryo to reveal that GDF-3 is a BMP inhibitor and as such, can act
as a direct neural inducer within the frog ectoderm. These results were
confirmed using GDF-3 recombinant protein, which can neuralize individual
dispersed cells of the animal cap. Reduction of GDF-3 protein levels in the
endogenous context of embryonic stem cells further demonstrates that GDF-3 is
a physiological BMP inhibitor, as enhanced activation of the BMP pathway is
observed. To provide a possible biochemical explanation for GDF-3 activity, I
performed immunoprecipitation binding assays and found that GDF-3 protein
binds to BMP proteins, both in cells and in solution.

2.9 Chapter analysis
These findings identify GDF-3 as an inhibitory TGF-β superfamily ligand,
together with BMP15, GDF9, BMP3, Xnr3 (a Nodal-related frog-specific ligand),
and the divergent ligands LeftyA and LeftyB (Levine and Brivanlou, 2006a;
Tabibzadeh and Hemmati-Brivanlou, 2006). Of these ligands, BMP15, GDF9,
LeftyA, and LeftyB are also missing the fourth canonical cysteine. In addition,
Xnr3 has a ‘shifted’ fourth cysteine that is a few amino acids earlier than in the
canonical location. BMP3 has the normal complement of cysteines.
The mechanism of inhibition for most of these ligands has not been
determined. However, it is very interesting to consider the role of the ‘missing’
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cysteine. As this cysteine is involved in intermolecular interactions (Groppe et
al., 2002), and I have shown that GDF-3 protein interacts physically with BMP
proteins, it is possible that GDF-3 forms a heterodimer with BMP proteins that
has an atypical structure that inhibits the ability of BMP ligands to signal.
However, several of my findings suggest that this model cannot explain fully the
inhibitory activity of GDF-3. First, heterodimers are formed between the prepro
forms of ligands before secretion from the cell of origin but I found that GDF-3
mature protein can inhibit BMP signaling when presented in solution with mature
BMP proteins. Second, I found that introducing the ‘missing’ cysteine into the
GDF-3 mature domain did not eliminate the ability of GDF-3 to inhibit BMP
signaling. I did not determine whether endogenous GDF-3 mature protein is
present as a monomer or dimer, but the recombinant GDF-3 protein that I used
is described by the company (Peprotech) as being a dimer.
To determine which other features of the GDF-3 protein account for its
inhibitory function, I also considered the prepro domain because cleavage
mutants of other TGF-β ligands (particularly Nodal-related ligands) have been
shown to act as BMP inhibitors (Eimon and Harland, 2002; Haramoto et al.,
2004; Yeo and Whitman, 2001) and GDF-3 is present endogenously mainly in
the prepro form. I found that both the cleavage mutant and the prepro domain of
GDF-3 can inhibit BMP signaling. Interestingly, a double mutant of the ‘missing’
cysteine and the cleavage site lost most ability to block BMPs. Therefore, the
ability of GDF-3 to inhibit BMP signaling resides redundantly in the prepro region
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of the protein and in the mature domain that is ‘missing’ the fourth cysteine. This
accounts for the inhibitory properties of GDF-3 and may inform the mechanisms
of other inhibitory ligands.
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CHAPTER 3: GDF-3 IN STEM CELLS
In the previous section, I established that GDF-3 is a BMP inhibitor. I next
sought to characterize the outcome of this activity in the endogenous contexts of
GDF-3 expression. My initial interest in GDF-3 began with the observation that
its expression is tightly correlated with stemness in both human and mouse
embryonic stem cells (Sato et al., 2003). I therefore returned to stem cells to
study GDF-3 function through gain-of-function in human embryonic stem cells
and reduction-of-function in mouse embryonic stem cells.

3.1 - GDF-3 expression is associated with pluripotency in mammlian cells
To confirm the micro-array findings that GDF-3 expression is associated
with the undifferentiated state of embryonic stem cells (Sato et al., 2003), I
performed RT-PCR to examine GDF-3 mRNA levels in both human and mouse
embryonic stem cells. I cultured H1 human embryonic stem cells and 129Ola
mouse embryonic stem cells either in conditioned media (CM) or LIF,
respectively (that maintain their undifferentiated states) or in the absence of
these factors to allow differentiation. I found that GDF-3 is present in the human
embryonic stem cells grown in CM and the mouse embryonic stem cells grown
in LIF, and it was significantly reduced when these embryonic stem cells were
allowed to differentiate, together with the decreased expression of other stem
cell markers (Figure 12).
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Figure 12

Figure 12: GDF-3 expression is associated with stemness in human and mouse
embryonic stem cells. Human BGN1 embryonic stem cells (HES) and mouse
CJ7 mouse embryonic stem cells (MES) were cultured in the presence of MEFconditioned medium (CM) or leukemia inhibitory factor (LIF) to maintain
stemness (lanes 1 and 3, respectively), or these treatments were removed to
allow differentiation for four (HES) or three days (MES) (lanes 2 and 4). GDF-3,
Oct4, Sox2, and Nanog are markers of stemness; β-actin is shown as a loading
control.
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3.2 – GDF-3 is a BMP inhibitor in pluripotent mammalian cells
In my analysis of GDF-3 activity in embryonic stem cells, I next sought to
confirm its role as a BMP inhibitor in this context. My results in Chapter 2.4 of
this thesis demonstrated that GDF-3 is an endogenous BMP inhibitor in mouse
embryonic stem cells. To determine whether GDF-3 over-expression could
suppress exogenous BMP signals in a pluripotent mammalian context, I
performed experiments in P19 cells into which I transfected mGDF-3 with or
without mBMP4. In order to generate a robust BMP signal this system was
complemented by co-transfection of downstream signaling components: Smads
1, Smad 4, and OAZ (Hata et al., 2000). Figure 13 shows that in P19 cells,
mGDF-3 reduced BMP4 signaling. This evidence confirms that GDF-3 is an
inhibitory member of the BMP-GDF subfamily of TGF-βs.
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Figure 13

Figure 13: GDF-3 inhibits BMP4 signaling in P19 mouse teratoma cells.
Luciferase activity (in arbitrary units) was analyzed using a BMP responsive
element driving a luciferase reporter (BRE-Lux) in P19 cells expressing BMP4
alone (column 2), BMP4 together with GDF-3 (column 3), or GDF-3 alone
(column 4). All P19 cells were transfected with BRE-Lux, together with BMP
signaling components Smad1, Smad4, and OAZ.
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3.3 - GDF-3 partially maintains pluripotent cell types in human embryonic
stem cells
It has previously been shown that exogenous BMP signaling from classic
BMPs promotes extra-embryonic cell fate differentiation in human embryonic
stem cells (Xu et al., 2002). To determine whether, as a BMP inhibitor, GDF-3
can oppose these functions, I transiently transfected BGN1 or RUES1 human
embryonic stem cells with GDF-3 plasmids and cultured these cells in CM that
maintains the undifferentiated state or in the absence of CM, allowing
heterogeneous differentiation, and I cultured them in the presence or absence of
BMP4 protein. Figure 14A shows that GDF-3 transfected BGN1 human
embryonic stem cells maintained significant levels of the pluripotency markers
Oct3/4 and Nanog in conditions that normally promote differentiation. In RUES1
human embryonic stem cells, I found that GDF-3 over-expression resulted in
limited maintenance of pluritpotency markers upon differentiation, but only upon
the combined treatment of BMP4 protein and the absence of conditioned
medium (Figure 14B). It is unclear what accounts for differences in the strength
of GDF-3 activity between human embryonic stem cells lines, but it is possible
that variable levels of endogenous GDF-3, or different transfection efficiencies
account for these observations.
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Figure 14: GDF-3 supports stemness markers in human embryonic stem cells
and reduces extra-embryonic differentiation. (A,B) BGN1 (A) or RUES1 (B)
human embryonic stem cells were transiently transfected with empty vector (V)
or with a vector containing GDF-3 (G). Beginning 24 hours after transfection,
cells were treated for four days with conditioned medium (CM), non-conditioned
medium (no CM), conditioned medium containing 10 ng/mL recombinant human
BMP4 protein (CM + BMP4), or non-conditioned medium with BMP4 (no CM +
BMP4). Cells were then lysed and proteins were analysed by western blot for
Oct4, Sox2, and Nanog (stem cell markers) and for cyclophilin B or tubulin
(loading controls). (C) RUES1 HES were cultured for four days in the presence
or absence of recombinant human GDF-3 protein (1 ug/mL) in CM, no CM, or
CM containing rhBMP4 (10 ng/mL). Cells were harvested for RNA and real-time
PCR was performed to analyze expression of the trophoblast marker cdx2,
normalized to levels of a housekeeping gene, tbp1.
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I next tested whether GDF-3 had the complementary ability to inhibit
BMP-induced differentiation to extra-embryonic trophoblast. I cultured RUES1
cells in conditioned media, non-conditioned media, or conditioned media with
BMP4 protein in the presence or absence of recombinant human GDF-3 protein
(rhGDF-3). GDF-3 significantly reduced the expression of cdx2, a marker of
trophoblast, either during heterogenous or directed trophoblast differentiation
(Figure 14C). This demonstrates that GDF-3 contributed to the maintenance of
pluripotent gene expression and the inhibition of differentiated extra-embryonic
gene expression in human embryonic stem cells.

3.4 - GDF-3 activity is required for the full spectrum of in vitro
differentiation of mouse embryonic stem cells grown without LIF
In contrast to the differentiative effect of BMP signaling in human
embryonic stem cells, it has been shown that moderate levels of BMP signaling
synergize with LIF to support the pluripotent state in mouse embryonic stem
cells while high levels of BMP activation, as those obtained with a constituitively
active BMP receptor, promote differentiation (Ying et al., 2003).
To study the required functions of GDF-3 in mouse ES, I obtained a
genetrap embryonic stem cell line (Sanger Insitute line AD0857), in which the βgeo (a β-gal/neomycin resistance fusion) insertion is located in the single intron
of the GDF-3 gene and creates a splice-fusion product with exon 1 (Figure 15A).
Exon 1 of GDF-3 contains approximately one third of the prepro domain and has
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no function upon over-expression in frog embryos (data not shown). Therefore, I
predicted that this allele could produce a reduction-of-function for GDF-3. I
characterized the phenotype of the heterozygous genetrap ES through
expression and functional analysis. I first confirmed that these ES had
significantly reduced levels of GDF-3 protein (Figure 15B).
Then, I examined the phenotypic effects of reduced GDF-3 levels. I
cultured the heterozygous genetrap ES in the presence and absence of LIF.
When cultured in the presence of LIF, wild-type mouse ES cells can be
maintained in the undifferentiated state but in the absence of LIF, these cells
differentiated to a flattened morphology after four days of culture. In contrast,
genetrap cells maintained a normal, undifferentiated morphology even in the
absence of LIF (Figure 15C). I analyzed these cells with molecular markers to
determine what cell fates were formed and found that, in the absence of LIF,
wild-type cells expressed high levels of brachyury, a mesoderm marker, and low
levels of Oct3/4 and Sox2, markers of the undifferentiated state, and of FGF5, a
marker of pluripotent epiblast; genetrap cells had reduced levels of brachyury
and maintained significant levels of Oct3/4, Sox2, and FGF5 (Figure 15D).
These findings suggest that the reduced level of GDF-3 protein precludes
normal differentiation.
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Figure 15: Reduction of GDF-3 in mouse embryonic stem cells (MES) blocks
normal differentiation. (A) The genetrap allele AD0857. The β-geo insertion (βgal/neomycin fusion protein; blue) is in the single intron of the GDF-3 gene. The
prepro domain (red) of GDF-3 protein is on exon 1 and 2. The mature domain of
GDF-3 protein (green) is entirely within exon2. Normal splicing of the
endogenous locus produces GDF-3 mRNA. Splicing of the genetrap (GT) locus
produces AD0857 mRNA containing a fragment of the prepro coding sequence
and the β-geo insertion. (B) Western blot of WT MES and GT MES showing
GDF-3 prepro and mature forms. Tubulin is a loading control. (C) Morphology of
WT and GT ES after four days of culture in the with or without LIF (x10). (D) RTPCR of WT and GT ES after four days of culture in the presence or absence of
LIF. The following markers were used: FGF5 (pluripotent epiblast), BU
(mesoderm), Sox2 (stem/epiblast/neural precursor) and Oct3/4 (stem/epiblast),
β-actin (loading control). (E) The percent of hanging drops containing cells of
each condition (WT and GT with and without LIF) that formed embryoid bodies.
(F) Day 2 embryoid bodies for WT cells cultured in the presence of LIF, and GT
cells cultured in the presence or absence of LIF (x10 magnification). Scale bar is
200 µm. (G) RT-PCR of markers for early embryonic cell fates on day 8
suspension culture embryoid bodies. The following markers were used: Oct4
,FGF5, Sox2, Pax6 (neural), Rax (anterior neural), Nkx2.5 (cardiac mesoderm),
Flk-1 (endothelial mesoderm), scl-1 (blood), AFP (endoderm), β-actin (loading
control). No RT cotrol is shown for β-actin.
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I tested the ability of the heterozygous genetrap cells to remain
functionally pluripotent even in the absence of LIF by assaying for the formation
of embryoid bodies (EBs). Upon culture in hanging drops, undifferentiated
embryonic stem cells form aggregates, called EBs, that differentiate into many
types of embryonic tissue. Wild-type and genetrap cells grown in the presence of
LIF formed EBs in 100% of the hanging drops (+/- 0%). While wild-type cells
grown in the absence of LIF rarely formed EBs (6% +/- 13%), genetrap cells
without LIF formed EBs in 79% (+/-25%) of the hanging drops (Figure 15E).
However, these ‘EBs’ were much smaller and less compact than EBs produced
by cells grown in LIF (Figure 15F).
I examined the EBs on day 8 of suspension culture by RT-PCR to
determine whether a reduction of GDF-3 levels alters cell fate outcomes in
differentiated mouse embryonic stem cells. I studied mRNA levels of
stem/primitive markers (Oct4, Fgf5, Sox2), neural markers (Sox2, Pax6, Rax),
mesodermal markers (Nkx2.5, Flk-1, Scl-1), and endodermal markers (AFP,
HNF-3β (data not shown); (Figure 15G). While wild-type or genetrap cells grown
in the presence of LIF can give rise to a full profile of differentiated cells types,
AD0857 cells grown in the absence of LIF retain a primitive phenotype with
limited neural differentiation. However, these cells do not form mesoderm or
endoderm, suggesting that the spheres formed are not true ‘embryoid bodies.’
This evidence establishes that wild-type levels of GDF-3 activity are required for
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normal in vitro differentiation of the three embryonic germ layers: the signature
of pluripotency.
I next sought to determine whether reduction of GDF-3 levels also
precludes normal differentiation in vivo by injecting stable-GFP expressing wildtype or heterozygous genetrap ES cells cultured in the presence or absence of
LIF into mouse blastocysts and assessing tissue contribution at mid-gestation
(e9.5). In this assay of ES cell potential, I found that neither wild-type nor
genetrap ES cells cultured without LIF gave rise to any differentiated cells within
the host embryo. Further, I did not observe any difference in tissue contribution
between wild-type and genetrap ES cultured in the presence of LIF, as both
differentiated normally (data not shown). These data suggest that the effects of
reduced GDF-3 levels on ES cell potential are confined to in vitro differentiation,
possibly due to the greater robustness of in vivo development.

3.5 Chapter Summary
These experiments reveal that GDF-3 has dual roles in the context of
embryonic stem cells, both of which are consistent with its role as a BMP
inhibitor. I found that, as in the frog embryo, GDF-3 in pluripotent mammalian
cells inhibits BMP signaling. The outcome of this activity in human embryonic
stem cells is that GDF-3 supports the undifferentiated state, partially maintaining
the expression of stem cells markers in multiple differentiation contexts.
Specifically, it plays a role in reducing differentiation to the extra-embryonic
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trophoblast, a fate that is induced by classic BMP ligands. In mouse embryonic
stem cells, I found that reduced levels of GDF-3 protein, produced through a
genetrap allele, preclude normal differentiation. Instead, cells that are
heterozygous for the genetrap allele show maintenance of stem cell/epiblast
markers and the ability to form embryoid bodies, even after they have been
cultured in the absence of LIF. Together, these data establish that GDF-3
regulates both of the key features of embryonic stem cells – the ability to
maintain stemness and the ability to differentiate.

3.6 Chapter analysis
GDF-3 achieves these functions in a species-specific manner that is
consistent with, and extends, previous reports of BMP function in stem cells (Xu
et al., 2002; Ying et al., 2003). I present four possibilities to explain the speciesspecificity of BMP/GDF activity in stem cells.
First, it is possible that distinct signaling profiles regulate the early cell
fate decisions of human and mouse embryos. This is consistent with
observations that LIF is sufficient to maintain stemness in mouse mES, but not
in human ES (Daheron et al., 2004; Reubinoff et al., 2000; Sato et al., 2004) and
that Nodal signaling is required for stemness in human ES, but not in mouse ES
(James et al., 2005).
A second possibility is that human and mouse ES cells possess different
sensitivities to BMP signaling and that different levels of effective BMP signaling
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in these cells produces their disparate phenotypes. According to this concept,
the absence of BMP signaling could promote neural differentiation, very low
levels could promote stemness, and higher levels of BMP signaling could
promote differentiation to extra-embryonic or mesendoderm cell fates. It is
known that BMPs can act as morphogens, creating distinct cell fates based on
different concentrations of the ligand at a given time window (Wilson et al.,
1997). This concept is further supported by the observation that moderate BMP
activation in mouse embryonic stem cells, if presented together with LIF,
promote stemness; however, strong activation of the BMP pathway promotes
differentiation, even in the presence of LIF. Thus, it is probable that GDF-3
expression helps to establish a BMP activity gradient.
Third, it is possible that human and mouse embryonic stem cells
correspond to distinct stages of in vivo development. If mouse embryonic stem
cells represent a slightly later cell type than the inner cell mass of the blastocyst,
like the early epiblast, the role of BMP signaling in these cells is supported by
the observation that decreased BMP signaling (through the BMPR1A knockout)
result in precocious differentiation, suggesting that BMPs help to maintain the
pluripotency of early epiblast cells (Di-Gregorio et al., 2007). Fourth, it is
possible that the distinct signaling status and effect of GDF-3 in human and
mouse ES could be an artifact of different derivation and culture conditions.
GDF-3 is first expressed zygotically in the blastocyst, and is somewhat
enriched in the inner cell mass, the region that will form the entire mouse
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embryo and from which embryonic stem cells can be derived. GDF-3 is therefore
one of the earliest BMP inhibitors expressed in the mammalian embryo. Recent
studies profiling genome-wide expression in early mouse embryos describe
expression of only one other possible BMP inhibitor, Lefty, in pre-implantation
mouse development (in addition to GDF-3) (Hamatani et al., 2004; Wang et al.,
2004).
The localization of GDF-3 at blastocyst stages is particularly interesting
because it is known that BMP4 is expressed at this stage (Coucouvanis and
Martin, 1999) but that BMP signaling is not active (James et al., 2005). If GDF-3
is the unique BMP inhibitor at this stage, it would play a critical role in the
earliest cell fate decisions of the mammalian embryo, that is, whether a cell
should be inner cell mass or trophoblast and within the inner cell mass, whether
a cell should become future embryonic tissue, or primitive endoderm.
In agreement with this suggestion, BMP promotes primitive endoderm in
the mouse embryo (Coucouvanis and Martin, 1999) and trophoblast in human
embryonic stem cells (Xu et al., 2002). I found that GDF-3 blocked BMPinduced trophoblast differentiation of human embryonic stem cells and it has
been shown that BMP inhibition is sufficient to maintain human embryonic stem
cells in the undifferentiated state, together with FGF activation (Xu et al., 2005).
These findings demonstrate the importance of an inhibitory signal (rather than
an activating, instructive signal) in establishing the inner cell mass/stemness fate
and highlight the potential roles of ‘negative’ information.
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CHAPTER 4: THE ROLE OF GDF-3 IN MOUSE
EMBRYOGENESIS

The previous sections established the mechanism of GDF-3 function and
its activity in embryonic stem cells. I next extended this analysis to determine
other developmentally-relevant contexts for GDF-3 and to study its function in
these settings through a reduction of GDF-3 protein levels in the mouse embryo.

4.1 - Expression of GDF-3 during early mouse embryogenesis
I first analyzed the expression of GDF-3 during early mouse
embryogenesis to gain an understanding of what role it may play in
development. Previously, GDF-3 was found to be expressed in e12.5-e15.5
embryos in bone (Jones et al., 1992b), so I focused my studies on early
embryonic expression. Temporal analysis of GDF-3 expression by RT-PCR
revealed that GDF-3 expression was present at blastocyst and gastrula stages
and up-regulated at e8.5 (Figure 16A). Using in situ hybridization to study GDF-3
mRNA expression spatially, I found that GDF-3 is expressed within the inner cell
mass of the blastocyst embryo; however, expression was weak and I cannot rule
out lower levels of GDF-3 transcripts in the surrounding trophoblast cells (data
not shown). Therefore, I performed immunofluorescence to localize GDF-3

66

protein. I found that GDF-3 protein is expressed throughout the blastocyst
embryo and is either membrane-associated or extracellular (Figure 16B).
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Figure 16: Expression of GDF-3 in early mouse development. (A) RT-PCR
showing GDF-3 mRNA expression during pre-implantation (2-4 cell through
blastocyst) through mid-gestation development (e6.5-e10.5). HPRT is shown as
a loading control, no RT is a negative control for genomic DNA. (B)
Immunofluorescence for GDF-3 protein (red) in a mouse blastocyst. Nuclei are
visualized with Sytox green. The bottom panel shows a control with no primary
anti-GDF-3 antibody. Scale bar is 50 µm.
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Figure 16
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Subsequently, GDF-3 mRNA is confined to the node and the tissue immediately
anterior to the node during gastrulation (Figure 17A,B). Shortly after gastrulation,
GDF-3 mRNA is expressed in the forming cranial neural crest and in the ventral
neural tube and notochord (Figure 17E,F).
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Figure 17: Expression of GDF-3 mRNA in early post-gastrulation mouse
embryos. In situ hybridization for GDF-3 mRNA is shown at e7.5 (A), e8.0 (B),
and e8.5 (C,D). A 10 µm frozen section after whole mount in situ hybridization is
shown in (D). (A) Lateral view, anterior is to the right, (B) posterior view, (C)
dorsal view. Scale bar is 200 µm.
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I next extended my characterization of GDF-3 expression from e7.75
through e8.5 embryos by analyzing the expression of the LacZ transgene
inserted as a genetrap (see Chapter 3.4). I found LacZ protein only in the late
node and notochord of embryos at these stages. This is distinct from the pattern
of GDF-3 mRNA detected by in situ hybridization, which also includes staining in
the prospective neural crest, and rostral ventral spinal cord. I considered that
possibly this discrepancy reflects a lag in translation, such that GDF-3 locus
mRNA produced at e8.0 in the node results in LacZ translation at e8.5 in nodederived structures, but not yet in structures that are newly expressing GDF-3
locus mRNA. However, I detected no LacZ protein in the e9.5 embryo, making
this possibility unlikely. Alternatively, it is possible that the hybrid mRNA for
intron 1 of GDF-3 and the LacZ coding sequence is either regulated posttranscriptionally in a tissue-specific manner, or that the hybrid protein is
produced, secreted, and the LacZ staining that I observed represents the target
tissue of GDF-3 secretion.

73

Figure 18

Figure 18: Expression of GDF-3 locus LacZ in early post-gastrulation mouse
embryos. Red-GAL staining of embryos that are heterozygous for the LacZ
genetrap insertion at e8.0 (A, yellow) and e8.5 (B, maroon). Embryos are shown
in dorsal views. Scale bar is 200 µm.
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To begin to study the role of GDF-3 in adult stem cells, I performed in situ
hybrdization on adult testis and found that GDF-3 is surprisingly expressed
specifically in the most differentiated cell types such as spermatids (Figure 19A).
Using immunofluorescence, I found that GDF-3 protein is also present in the
spermatids (Figure 19C-E), specifically localizing to the acrosome of the sperm
(Figure 19F,G), as determined by co-localization with peanut agglutinin (G).
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Figure 19: Expression of GDF-3 during male gametogenesis. (A) In situ
hybridization shows GDF-3 expression in the mature spermatids in the testis. (B)
A sense probe control for GDF-3 expression. (C,E) Immunofluorescence for
GDF-3 showed protein expression in the mature spermatids. (D) Negative
control for immunofluorescence performed by pre-absorbing anti-GDF-3 primary
antibody with 10X recombinant GDF-3 protein. (F,G) Individual mouse sperm
stained for GDF-3 protein (red) and the nucleus (F, green) or the acrosome (G,
green). (A-E) were performed on 10 µm frozen sections of testis. (A-D) 10X
magnification, (E) 40X magnification, scale bar is 200 µm. (F,G) 63X
magnification, scale bar is 5 µm.

76

Figure 19
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5.2 - Reduction-of-Function Analysis of GDF-3
To study the required roles for GDF-3 during mouse embryogenesis, I
examined the effects of a genetrap allele that interrupts the GDF-3 genomic
locus (described in Chapter 3.4). We also pursued creation of a conditional
knockout for GDF-3, but this work could not be addressed within the time
limitations of the thesis, and was not characterized.
Heterozygous genetrap embryonic stem cells (from Sanger Institute) were
injected into host blastocysts to create chimeras, that were then used to
propagate a genetrap (GT) line of mice. I tested the efficiency of loss of GDF-3
protein by deriving embryonic stem cells from blastocysts that were wild-type,
heterozygous, or homozygous for the genetrap allele and found reduced GDF-3
protein in the heterozygous line and very low levels of GDF-3 protein in the
homozygous genetrap line (Figure 20).
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Figure 20

Figure 20: Genetrap AD0857 of the GDF-3 mouse genomic locus results in loss
of GDF-3 protein. Western blot of full length (prepro) GDF-3 protein in wild-type
(Wt), heterozygous (Het), and homozygous genetrap (GT) mouse embryonic
stem cells. Tubulin is shown as a loading control. Upon very high exposure, a
GDF-3 band can be seen in the homozygous GT cells.
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I first observed that homozygous genetrap mice were present in the
colony, but at lower levels than predicted (15/120 animals born of heterozygous
matings; 12.5% observed versus 25% predicted). This suggested a partially
penetrant embryonic lethality and I began dissecting embryos from timed
matings to determine the embryonic stage of lethality. Beginning at e7.75 (early
allantoic bud stage) through e8.5 (neurula stage), I found a dramatic phenotype
in 42% of homozygous mutant embryos, (Figure 21, Table 1). The most severely
affected embryos arrested at e8.5, but a fraction that had a similar, but slightly
milder phenotype, survived to e9.5.
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Figure 21: Gross morphological phenotype of affected homozygous GDF-3
genetrap embryos, compared with wild-type littermates. The following stages are
shown: e7.75 (A,B), e8.0 (C,D), e8.5 (E,F), e9.5 (G,H). Homozgyous genetrap
embryos are in the right column. *1 highlights the growth of the embryo, outside
of the extra-embryonic membrances, *2 denotes the ‘rod’ shape of the embryo,
and *3 shows the anterior neural truncation. In the first three rows, anterior is left
and dorsal is up. In the fourth row, anterior is up and dorsal is right. Scale bar is
200 µm (A-F) or 400 µm (G,H).
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Table 1: Frequency of GDF-3 genetrap embryos and mice.

Embryonic

Wild-type

Heterozygous

Homozygous

Phenotype

Stage

% (n)

% (n)

% (n)

% of
homozygous
(n)

e6.5-e7.5

16.5% (33)

57% (113)

25% (54)

0% (0)

e7.75-e8.5

25% (73)

54% (160)

21% (64)

42% (27)*

e9.5

19% (9)

40% (19)

34% (20)

10% (2)

Adult

27% (32)

61% (73)

12.5% (15)

0% (0)

* Four of these embryos were degenerated, with only the yolk sac remaining.
Twenty three of these embryos displayed the common phenotype, shown in
Figure 21A,C,E.
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4.3 – Characterization of the phenotype of affected homozygous GDF-3
genetrap embryos
The gross phenotype at e8.5-e9.5 was most notable for the following
elements: the embryo is not surrounded by extra-embryonic membranes, but is
connected to them in its posterior region (Figure 21D *1); the embryo does not
have an open neural plate but is instead a closed rod (Figure 21F *2); and the
embryo seems to lack anterior neural structures (Figure 21H *3).
This gross phenotype is reminiscent to the phenotype of mutants that
have perturbed formation of the anterior visceral endoderm (Kinder et al.,
2001a). The phenotype also resembles embryos that are mutant for FoxA2 (Ang
and Rossant, 1994; Weinstein et al., 1994), which lack anterior visceral
endoderm and the node/notochord, and to sub-classes of Nodal hypomorph
embryos that have strongly reduced or absent notochord (Lowe et al., 2001). To
analyze these tissues directly, I characterized the expression of molecular
markers. I found that, at e6.5, the anterior visceral endoderm markers Lim1 (5/5
homozygous mutant embryos, Figure 22B) and Hesx1 (3/3 homozygous mutant
embryos) were normal, suggesting that this tissue is formed normally. I next
examined the formation of the primitive streak, node, and anterior mesoderm by
analyzing Brachyury (BU) and FoxA2 expression at e7.5, which were both
normal (10/10 and 7/7 homozygous mutant embryos, respectively, Figure 22D,
F), indicating that the anterior-posterior axis is normally established, that the
primitive streak is formed normally, and that the node was induced normally.
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Figure 22: Anterior visceral endoderm, primitive streak, and node induction are
normal in affected homozygous genetrap GDF-3 embryos. Lim1 expression
marks the anterior visceral endoderm in a wild-type embryo and mutant e6.5
embryo (A,B scale bar is 150 µm). FoxA2 expression marks the node in e7.5
embryos (C,D scale bar is 200 µm). Brachyury expression marks the primitive
streak, node, and anterior axial mesoderm in e7.75 embryos (E-G, scale bar is
200 µm). Anterior is to the left (A), posterior is to the right (P).
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Figure 22
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To analyze more carefully the phenotype of affected mutant embryos, I
sectioned them at e8.5 and e9.5. I found that, strikingly, the embryos possessed
a notochord, but it was located at the extreme ventral edge of the embryo
(Figure 23). In a subset of late e8.5-e9.5 embryos, I even observed a notochord
at the opposite end of the dorsal-ventral axis of the embryo from a
morphologically normal heart (Figure 23). I next analyzed the neural tube and
found that at early stages (e7.75-early e8.5), it opened into the body of the
embryo, rather than out towards the dorsal edge of the embryo (Figure 24I,M).
At later stages (late e8.5-e9.5), the neural tube was closed, as in wild-type
littermate embryos (Figure 23).
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Figure 23

Figure 23: Section of an affected homozygous GDF-3 genetrap e9.0 embryo,
after in situ hybridization for Brachyury, to identify the notochord (red). The
neural tube (blue) and heart (orange) are identified by their typical morphology.
Ectopic tissue, of unknown character, is present in the interior of the embryo.
This is a pseudo-colored image of a 10 µm frozen section after whole mount in
situ hybridization. Scale bar is 150 µm.
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Molecular markers revealed that affected homozygous mutant embryos
had a dorsal-ventral arrangement of tissues as follows: heart/endoderm, dorsal
neural tube, ventral neural tube, then notochord, rather than the typical dorsalventral arrangement of neural tube, notochord, then endoderm and heart (Figure
24). For instance, Fgf8 (cardiac progenitors), FoxA2 (foregut) and Hex
(endoderm) showed ‘dorsal’ staining at e8.5 (2/2, 4/6, and 2/2, respectively). In
the neural tube, Wnt1 and Pax3 stained the most internal, ‘dorsal’ structures (3/4
and 5/6, respectively), while FoxA2 stained a floorplate like structure in the
‘ventral’ neural tube (5/6). Shh was strongly downregulated, but present in the
ventral notochord (2/2).
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Figure 24: Marker analysis of dorso-ventral arrangement of tissues in affected
homozygous GDF-3 genetrap e8.0-e8.5 embryos. Mutant embryo sections are
shown on the left, wild-type littermates are shown on the right. The following
markers were used: Hex (endoderm, A,B); Fgf8 (cardiac progenitors, C,D);
FoxA2 (notochord, floorplate, foregut, E,F); BU (notochord, G,H); Pax3 (dorsal
neural tube, I,J); Wnt1 (dorsal neural tube, K,L), Shh (notochord, floorplate,
M,N). The same magnification was used for all sections but slight variations in
embryonic stage and the position of the section along the anterior-posterior axis
account for the differences in size. (O,P) Abstract version of the tissues in
homozygous genetrap (O) versus wild-type (P) embryos. The notochord is
shown in maroon, the heart and endoderm in orange, and the neural tube in
blue, with the dorsal structures being a darker shade. Dorsal is up (D), ventral is
down (V). Scale bar is 150 µm.
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Figure 24
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Ventral to the neural tube, a ‘cap’ of notochord was present (10/11
affected homozygous mutant embryos), that was positive for BU (10/11, Figure
24G) and FoxA2 (5/6, Figure 24E). Interestingly, Shh was severely reduced in
this structure (2/2), indicating a possible second role for GDF-3 in the
maintenance of Shh expression in the notochord (Figure 24M).
This cap was broader than the typical wild-type notochord and in
e7.75/e8.0 affected homozygous embryos, I observed a wide stretch of BUpositive cells emanating from the node and extending anteriorly on the ventral
surface of the embryo. This expression was present as a continuous cap or with
small gaps. In contrast to the wild-type embryos, in which ventral observation
revealed two thin BU-positive columns of cells that lead anteriorly from the node,
joining to form the notochord, the affected mutant embryos displayed dispersed,
disorganized BU-positive cells on the ventral surface (10/11 sectioned, Figure
24G; 5/5 whole mount, Figure 25). This is the earliest molecular abnormality in
the GDF-3 genetrap embryos, and provides an important clue to the cause of
the phenotypic defects, discussed in Chapter 4.5-4.6.
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Figure 25: Notochord formation is perturbed in affected homozygous GDF-3
genetrap embryos. In situ hybridization for Brachury was performed on wild-type
(A,C) and homozygous GDF-3 genetrap embryos (B,D. At e7.75-e8.0, lateral
views (A,B) show that the primitive streak and node appear normal but ventral
views (C,D) show that notochord/head process mesoderm migration anteriorly
from the node is disorganized in the mutant embryos. Scale bar is 200 µm.
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Figure 25
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In addition to the abnormal overall dorsal-ventral patterning, another notable
feature of the homozygous genetrap mutant embryos is their lack of anterior
neural structures. I analyzed whether forebrain is induced in genetrap mutants
and found that Six3 staining is normal at e7.75-e8.0 (8/8) and is subsequently
lost by e8.5-e9.0 (2/5 have expression), as is Otx2, another anterior neural
marker (2/2 e7.5 have expression, 6/11 e8.5-9.0 have expression) (Figure 26).
This suggests that anterior neural structures are induced normally, but fail to be
maintained.
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Figure 26: Lack of forebrain maintenance in affected homozgygous GDF-3
genetrap embryos. In situ hybridization for Otx2 (A,B,C,D) and Six3 (E,F,G,H).
Homozgyous genetrap embryos (B,C,F,H) do not show forebrain markers at
e9.0-9.5 (B,F) but do show normal induction of forebrain markers at e7.0-e7.75
(C,H). Wild-type sibling embryos are shown in A,D,E,H. In A and B, embryos are
also stained for the lateral mesoderm marker Lim1. In E and F, embryos are also
stained for Brachyury, demonstrating the abnormal localization of the notochord
at the ventral extreme of the mutant embryo (F). Scale bar is 500 µm in A,B;
150 µm in C,D,G,H; 300 µm in E,F.
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Figure 26
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4.4 – BMP provides a repulsive cue to migrating node cells
I considered possible explanations for the abnormal axial mesoderm
morphogenesis based on the central observations that GDF-3 is a BMP inhibitor
whose expression in the post-implantation embryo begins at e7.5 in the node
and then notochord. This correlates with the place and time of the earliest
defects observed in the genetrap mutant.
As the notochord migration occurs along the distal-anterior edge of the
embryo, and BMP signaling is active at the opposite end, I hypothesized that
BMP signaling may negatively drive migration of this structure. I therefore
explored the effect of BMP protein (supplied by rhBMP4 beads) on migration of
the distal region of the e7.25 mouse embryo – the area of origin for the anterior
axial mesoderm and the future anterior neural tissue.
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To test this hypothesis, I analyzed the effect of exogenous BMP signaling
on the migration of node explants. The distal fifth of e7.25 embryos was
explanted and allowed to attach to a fibronectin substrate for several hours
(Figure 27A). Subsequently, beads carrying rhBMP4 (or control human serum
albumin (HSA)) protein were placed near the explant and then the explant was
cultured for 48 hours. During this time, cells migrated away from the explant both
as leading, dispersed cells and as a dense ‘sheet’.
I measured the distance from the center of the node explant to the edge
of the migrating cells, creating a ratio of the distance away from the beads, to
the distance towards the beads. I found that beads carrying rhBMP4 provided a
repulsive cue to cells migrating from the node, while control beads had no effect
on cellular migration (Figure 27B). The ratio of the distance away from the bead
over the distance toward the bead was 1.06 +/- 0.18 units in the control HSA
treated explants (five sets, with a total 15 explants, and 1.44 +/- 0.55 in the
BMP4 treated explants (five sets, with a total 20 explants). Figure 27B shows the
percent of explants (blue, control and red, BMP4) in each range of distance
ratios.
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Figure 27: BMP protein provides a repulsive cue to migrating node explant cells.
(A) On the left, an e7.25 mouse embryo that has been partially cut, showing the
distal region that would be explanted. On the right, an explant that has attached
to fibronectin for several hours, with beads (5X magnification, scale bar is 100
µm). (B) Percent of explants in each distance ratio category for BMP4 treated
explants (red) or control HSA explants (blue). The ratios were calculated as the
distance away from the bead over the distance towards the bead. (C,D) Nuclear
stain showing the node explant (highlighted in white), next to the beads (dark
circle with asterisk) containing BMP4 (C) or HSA (D), and the cells that have
migrated away from the explant (yellow). Scale bar is 50 µm. The arrows
indicate the distance measured for migration from the center of the explant to
the edges, although the explant in (C) continues beyond the margin of the image
(2.5X magnification).
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Figure 27
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The variability in the ratio of the BMP4 treated explants is most likely is
due to slight variations in the stage of the embryos and/or the size of the
explants, and therefore the cellular makeup of the extirpated distal region. For
instance, earlier embryos may have had a smaller population of perspective
axial mesoderm cells in the distal tip, while slightly later embryos are closer to
the definitive node stage, when distal explants include more axial mesoderm
precursors. The two explants with a ratio of 2.8 and 2.9 (one of which is shown
in Figure 27C) were from slightly older embryos, approximately e7.4.
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4.5 Chapter Summary
These findings demonstrate that GDF-3 plays a critical role in the
patterning of the early embryo. My descriptive analysis found GDF-3 mRNA in
the sperm and within the embryo in the inner cell mass, node, notochord,
floorplate and neural crest of the mouse embryo, while a LacZ analysis found
the GDF-3 exon1-LacZ fusion exclusively in the node and notochord of headfold and early somite stage embryos. My reduction-of-function studies using the
genetrap line showed that GDF-3 is required for proper morphogenesis of the
post-gastrulation embryo, and that in its absence, the embryo has abnormal
dorsal-ventral patterning. Specifically, the ventral-most structure is the
notochord, followed by the neural tube, then the heart and foregut, rather than
the wild-type arrangment of heart and foregut, then notochord, and neural tube
(Figure 28). The notochord itself is abnormal, being broad and ‘dispersed.’ This
results in an embryonic lethality of affected embryos (42% of total homozygous
genetrap embryos) around e9.0 through e9.5 of gestation.
I hypothesized that the reduced GDF-3 levels allow for enhanced BMP
driven repulsory migration of the axial notochord and possibly the neural tube,
while preserving the normal location of more lateral cell fates such as heart and
foregut. I tested this by analyzing migration of an embryo explant in the
presence of beads containing BMP protein, which I found indeed drove repelled
migration. Together, these findings suggest that GDF-3 mediated inhibition of
BMPs is important for early patterning of the mouse embryo.
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Figure 28: Model of the phenotype of affected homozygous GDF-3 genetrap
embryos. Abstracted embryos of stage e7.75 (A,B) and e8.0 (C,D and sections
E,F) are shown, with a wild-type embryo on the left and a homozygous genetrap
embryo on the right. Axial mesoderm/notochord is shown in maroon, neural
tissue in blue, and heart/foregut is shown in light orange, and the primitive streak
in dark orange.
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Figure 28
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4.6 Chapter analysis
I compared the phenotype of the homozygous GDF-3 genetrap embryos
with those of other mouse mutants, to gain a greater understanding of the
processes regulating morphogenesis in the mouse embryo. Before this analysis,
it is important to note that a knockout of GDF-3 has been published (Chen et al.,
2006), with a distinct phenotype that it is discussed in Chapter 5.6.
The gross phenotype of the genetrap mutants most closely resembles the
FoxA2 knockout (Ang and Rossant, 1994; Weinstein et al., 1994), the severe
phenotype (class III) of the FoxH1 mutant (Yamamoto et al., 2001), and the
severe phenotype (class III) of Nodal hypomorph embryos (Lowe et al., 2001).
These three mutants perturb Nodal signaling. In addition, the genetrap
phenotype is similar to embryos with defects in the anterior visceral endoderm,
such as Otx2 and Lim1. Both of these classes of mutants result in embryos that
develop outside of the extra-embryonic membranes, have anterior neural
truncations, and a closed ‘rod’ structure.
However, there are several critical differences between the GDF-3
genetrap context and these other mutants. First, the aspects of the FoxA2 and
FoxH1 phenotype that resemble the gross GDF-3 phenotype reflect the role of
these genes in the anterior visceral endoderm. Perturbation of the anterior
visceral endoderm results in failure to convert the proximal-distal axis of the
early post-implantation embryo into the anterior-posterior axis of the gastrula,
and causes the relevant phenotype, beginning at e7.0 with distal outgrowth of
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the embryo (Kinder et al., 2001a). However, rescue of these genes only in the
visceral endoderm rescues the anterior-posterior axis and the relevant
phenotype (Dufort et al., 1998; Lowe et al., 2001; Rhinn et al., 1998; Yamamoto
et al., 2001).
In GDF-3 genetrap embryos, the anterior visceral endoderm is normal,
and the embryos display proper anterior-posterior polarity, as judged by
appropriate placement of the primitive streak, and the embryos are
morphologically normal until e7.75, when they begin to grow out anteriorly.
During gastrulation, the mammalian embryo undergoes explosive growth,
with the embryo increasing in cell number from approximately 600 to over
14,000 (in the mouse) (Snow, 1977). Therefore, cell fate specification,
morphogenesis, and growth must be tightly coupled. Perturbed outgrowth of the
embryo, either due to improper patterning of the proximal-distal axis, or to
abnormal migration and morphogenesis, may result in similar appearances.
Therefore, the ‘phenocopy’ of the late gross phenotype may be superficial and
does not reveal a mechanistic similarity in the genesis of the phenotype.
Several mutants of the Nodal pathway also display a lack of the node and
notochord. This is seen in embryos that lack epiblast FoxA2 or FoxH1, or
embryos mutant for GDF1-/-;Nodal+/-, the milder phenotypes of Nodal
hypomorphs (class 1, class II), and Smad2 epiblast mutants (Andersson et al.,
2006; Dufort et al., 1998; Lowe et al., 2001; Vincent et al., 2003; Yamamoto et
al., 2001). The loss of anterior axial mesoderm results in a ‘pin-head’ phenotype
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that is quite different from the GDF-3 genetrap phenotype. I clearly
demonstrated that the GDF-3 genetrap embryos form a node and notochord,
although the notochord is ‘misplaced’. This distinction highlights the critical
difference between an effect on cell fate in the Nodal pathway mutants, and the
effect on morphogenesis, which I observed in the GDF-3 genetrap mutant.
The molecular mechanisms of notochord induction are known, but the
signals that regulate mammalian notochord morphogenesis are poorly
understood, in part because processes that govern mammalian notochord
formation and migration are slightly different than in other vertebrates.
In the mouse, cells ingress as individuals or small clusters through the
primitive streak, by changing their adhesive properties and undergoing an
epithelial-to-mesenchymal transition as they leave the epiblast layer (Burdsal et
al., 1993; Nakatsuji et al., 1986). The early and mid-gastrula organizer that are
at the anterior edge of the primitive streak are the main source of the prechordal
plate, while the node contributes to the notochord (Kinder et al., 2001b).
Labeling of the mid-gastrula organizer reveals that the descendants migrate in a
column that is several cell diameters wide and deposit a trail of cells that
reaches caudally to the node (Kinder et al., 2001b; Sulik et al., 1994). During this
time and continuing through e8.5, the node regresses caudally, laying down the
notochord principally by cell accretion, though some cell division and convergent
extension also contribute to the elongation of the notochord (Sausedo and
Schoenwolf, 1994; Sulik et al., 1994). Initially, the notochord is incorporated into
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the endodermal layer and then converges more medially and folds off dorsally,
forming a rod in between the endoderm and neural tissue (Jurand, 1974).
In the frog, Activin has been implicated in endowing the notochord with
anterior-posterior polarity, to coordinate extension along this axis (Ninomiya et
al., 2004). However, this type of regulation does not explain the active anterior
cell migration that forms the prechordal plate and anterior notochord in the
mouse. In the Hex mouse mutant, the axial mesendoderm is induced, but does
not migrate anteriorly from the node (Martinez Barbera et al., 2000). As a result
of Hex loss, markers such as FoxA2 and Lim1 have expanded expression in the
node and reduced expression anteriorly. However, the phenotype of the Hex
mutant is usually explained as the result of a defect in induction of the most
anterior endoderm and prechordal plate (Brickman et al., 2000; Martinez
Barbera et al., 2000; Martinez-Barbera and Beddington, 2001; Zamparini et al.,
2006). It is important to determine whether BMP/GDF regulation of axial
mesoderm morphogenesis is related to a possible role of Hex in this process, or
whether GDF-3 provides the only genetic means to uncouple mammalian
notochord induction and migration.
One of the most notable features of the gross phenotype of homozygous
GDF-3 genetrap embryos is the anterior truncation that results from forebrain
loss. It is possible that the lack of GDF-3 in the notochord allows enhanced BMP
signaling that could abrogate forebrain maintenance. Similarly, in Chordin-/;Noggin+/- embryos, lack of these factors in the anterior mesendoderm results in
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failure to maintain forebrain tissue (Anderson et al., 2002). Further, in explants of
‘late-bud’ stage embryos, the forebrain has already been specified but markers
of forebrain disappear after prolonged culture or upon treatment with exogenous
BMPs, unless these explants are co-cultured with anterior mesendoderm (Yang
and Klingensmith, 2006). Alternatively, the dramatic reduction of Shh in the
notochord of affected mutants may indirectly prevent secretion of a necessary
forebrain maintenance signal. Of note, rostral Shh is lost in the Noggin/Chordin
double mutant (Bachiller et al., 2000).
Another possibility is that misplacement of the notochord relative to the
forebrain, or improper migration of the most anterior prechordal plate results in
the failure to maintain the forebrain. Several mouse mutants reveal the necessity
of this notochord-derived ongoing maintenance, as defects in mesendoderm
generally result in anterior neural truncations and post-gastrulation loss of
forebrain markers that were normally induced during gastrulation. Lack of
forebrain maintenance is seen in several Nodal pathway mutants that do not
induce anterior axial mesoderm, such as the Gdf1-/-;Nodal+/- mutant, the FoxH1
mutant, and a mutant that reduces Smad2/3 levels in the epiblast (Andersson et
al., 2006; Vincent et al., 2003; Yamamoto et al., 2001).
It is important to consider my observations of the GDF-3 genetrap
phenotype as a ‘reduction-of-function’ analysis. I studied the required functions
of GDF-3 in the mouse embryo using a genetrap allele that strongly reduces
production of GDF-3 protein. While the phenotype that I observed is dramatic,
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the allele itself is a ‘knock-down’ and the results must be interpreted in this
context. We also intended to create a conditional knockout of GDF-3, but this
work, done in collaboration with Regeneron was not successful.
Genetrap-based removal of GDF-3 probably results in partial
enhancement of BMP signaling, whereas a full null allele would cause greater
BMP pathway activation. As BMPs are morphogens, producing distinct cell fates
at distinct doses, this could show a different result from that of a true knockout,
and one that yields different information about the balance of BMP/GDF signals.
However, as I observed a probable effect of BMP signaling on chemotaxis, not
just cell fate, the residual GDF-3 protein might be of limited importance because
different doses of BMP could simply provide more or less notochord repulsion,
but produce the same type of phenotype.
It is possible that Noggin and/or Chordin mediate the rescue that allows
50-60% of homozygous genetrap embryos to escape the phenotype and survive
to adulthood. The shared expression of GDF-3, Noggin, and Chordin suggests
that only combined removal of all three factors would provide maximal BMP
activation. As a result, full removal of GDF-3 through a null allele would still only
produce an intermediate level of BMP inhibition.
In contrast to the phenotype of the GDF-3 genetrap mutation that I
observed, embryos that are missing either of the ‘classic’ BMP inhibitors Noggin
or Chordin have distinct, generally less severe phenotypes. Loss of Noggin
alone results in perinatal lethality, with defects in patterning of the neural tube
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and somites (McMahon et al., 1998). Loss of Chordin alone causes the majority
of mutant embryos to die perinatally, with head and neck abnormalities (Bachiller
et al., 2003; McMahon et al., 1998). However, a small percentage of Chordin
knockout embryos arrest shortly after gastrulation, with ‘ventralization’ that
includes reduced neural tissue and absence of dorsal mesodermal derivatives
such as the notochord and somites. Combined loss of Noggin and Chordin
results in embryonic lethality (Bachiller et al., 2000). These embryos do not
induce forebrain, but morphogenesis proceeds normally for the majority of the
embryo and the embryos arrest later in development. In addition, these embryos
have defects in left-right axis determination and in specifying and/or maintaining
certain cell fates, such as anterior notochord and trachea.
It is possible that the different phenotypes of the GDF-3 genetrap mutant
and the Noggin/Chordin double mutant reveal distinct requirements for BMP
inhibition mediated by atypical TGF-β ligands, such as GDF-3 in morphogenesis,
and by non-ligand factors such as Noggin and Chordin in establishing cell fate
(such as neural tissue and dorsal mesoderm). If this is the case, my work also
provides the first basis for genetically distinguishing the effects of BMPs on cell
fate determination and cell movement in the mouse embryo. Further, it highlights
the functional importance of the variety of regulatory mechanisms for the TGF-β
superfamily.
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CHAPTER 5: Does GDF-3 also act as a Nodal-like
agonist?
During this work, another group reported that GDF-3 is a Nodal-like
agonist required for early mouse development. My finding that GDF-3 acts as a
BMP inhibitor does not exclude the possibility that GDF-3 could have other
functions, and it is even possible that GDF-3 is a bi-functional ligand.
Throughout development, the reciprocal regulation of these two branches of
TGF-β family signaling is a very common phenomenon. These pathways are
oppositely regulated in human ES and possibly in the endogenous state of
mouse ES as well, reviewed in (Brivanlou and Levine, 2007). In the frog
embryo, blocking ongoing BMP signaling with concomitant activation of TGFβ/Activin/Nodal signaling is required for dorsal mesoderm induction and one
mechanism for this is intracellular competition for factors required in both signal
transduction pathways (Candia et al., 1997; Graff et al., 1996; Graff et al., 1994).
Given the importance of coordinately regulating these two pathways, a very
interesting and general mechanism could be bi-functional ligands. Nodal itself
has been shown to act as a BMP inhibitor, directly suppressing the activation of
Smad1/5/8 at the same dose at which it acts as a Smad2/3 activator (Yeo and
Whitman, 2001). However, my findings demonstrate that the major activity of
GDF-3 is mediated through its ability to inhibit BMP signaling, and Nodal-like
functions may be minor, or represent an artifactual activity.
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5.1 - Summary of the findings by Chen and colleagues
I present here a comparison of our data, together with data that directly
addresses the basis for our different conclusions. Chen et al made the following
central observations: 1) That GDF-3 is a ‘relative’ of xVg1. 2) GDF-3 overexpression in frog embryos causes a secondary dorsal axis and results in
mesoderm induction in animal caps. 3) GDF-3 can stimulate Activin/Nodalresponsive transcription in cell culture, and is inhibited by the Nodal inhibitor
Lefty. 4) GDF-3 interacts with Nodal receptors, in a complex with the co-receptor
Cripto. 5) GDF-3 is expressed in the inner cell mass and epiblast, but not in any
other tissues before mid-gestation (e9.5). 6) Loss of GDF-3 exon 2 results in
35% of homozygous mutant embryos arresting by e8.5, with a constriction at the
embryonic/extra-embryonic border, reduced anterior structures, ectopic,
abnormal mesodermal derivatives, and defects in extra-embryonic tissue.
Molecular defects include the failure of anterior visceral endoderm to be induced
and/or migrate, and defects in mesoderm and definitive endoderm induction.

5.2 - The relationship between GDF-3 and Vg1
GDF-3 was first cloned from a mouse e6.5 cDNA embryonic library by
homology to Xenopus Vg-1 (Jones et al., 1992b). However, it is not the
mammalian ortholog of Vg1. Mature mouse GDF-3 shares only 53% identity with
mature xVg1, while it has 84% identity with mature human GDF-3. Frog and
mammalian homologues of TGF-β superfamily ligands typically share greater
than 80% homology. More importantly, Vg1 retains the fourth cysteine, a
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defining feature of classic TGF-β superfamily ligands, and mutation of this
cysteine abrogates the ability of Vg1 to induce mesoderm (Joseph and Melton,
1998). Chen and colleagues do not identify GDF-3 as the true ortholog of Vg1,
but rather suggest that functions of Vg1 in the frog have been split between its
two close relatives, GDF-1(which has the same cysteine arrangement as Vg1),
and GDF-3, which represent functional homologs. As described in Chapter 2.1,
xVg1 is not syntenic with GDF-3, but is syntenic with GDF1. In summary, I find
no basis for considering GDF-3 to be a homolog of Vg1, but find that Vg1 is the
homolog of GDF-1, as judged by function, sequence, and synteny.

5.3 - GDF-3 over-expression in frog embryos and animal caps, and effects
on luciferase transcription
Secondary dorsal axis formation can result from either BMP inhibition or
Nodal-like activation. However, these two possibilities can be resolved by
assays such as over-expression in the animal cap in which BMP inhibition
results in direct neural induction, whereas Nodal activation induces mesoderm,
with secondary neural induction. As both groups performed the same assay,
with different results, I first analyzed the constructs that each group used to
produce GDF-3 mRNA. I studied GDF-3 over-expression with a construct
containing only the coding region of GDF-3. Other groups had used either a
construct containing both the coding region and untranslated regions (UTRs)
(Richard Harland and Julie Baker, personal communication), a construct
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containing the coding region followed by an SV40 polyA region (Chen et al.,
2006), or a chimeric GDF-3 mRNA encoding the prepro domain of BMP2 with
the mature domain of GDF-3 (Chen et al., 2006), a strategy that has been used
frequently in enhancing processing of TGF-β ligands. I therefore hypothesized
that the presence of the UTRs, the viral polyA, or the enhanced processing of
GDF-3 could promote higher levels of GDF-3 mature protein and thus account
for the different activities as a dose threshold effect.
To test whether the GDF-3 mRNA 5’ and 3’ UTRs enhanced production of
GDF-3 protein, I injected 1 pg, 10 pg, 100 pg, and 1000 pg of mRNA of each
construct and analyzed the amount of GDF-3 protein produced. As I
hypothesized, I found that the presence of the UTRs allowed production of
significantly more GDF-3 protein for each dose of mRNA injected (Figure 29A).
Therefore, injection of the coding region or the coding region plus UTRs
of GDF-3 give rise to very different ‘doses’ of GDF-3 protein. I predicted that at
high levels, the coding region alone could acquire mesoderm-inducing activity
and at low levels, the coding region plus UTRs would acquire BMP inhibitory
activity. I analyzed whether these different constructs possess different cell fate
inductive activities using the animal cap assay in the frog embryo. I found that,
throughout the dose range of the coding region alone construct, GDF-3 acted as
a BMP inhibitor, inducing neural tissue directly. I tested up to 3 ng/frog embryo
and still observed this phenotype but did not test higher doses because of nonspecific lethality of the embryos (data not shown). However, I found that at low
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doses (1, 10 pg), the coding region plus UTRs construct acted as a direct neural
inducer, the hallmark of BMP inhibition, while at higher doses (100 pg, 1 ng), it
acted as a mesoderm inducer, a classic response to Nodal signaling (Figure
29A).
In addition to my analysis of cell fate in animal caps, I tested the ability of
GDF-3 constructs to induce the typical elongated morphology of dorsal
mesoderm in animal caps. I injected RNA for increasing doses of GDF-3 CDS
alone and GDF-3 CDS plus UTRs. I found that the CDS alone did not induce
elongated dorsal mesoderm and caps maintained a spherical shape, similar to
uninjected caps or caps injected with Noggin, another BMP inhibitor. In contrast,
the CDS plus UTRs induced dorsal mesoderm elongation at 100 pg and 1 ng of
RNA injection (Figure 29B).
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Figure 29: Dose effect of GDF-3 over-expression in frog embryos. (A) Overexpression of GDF-3 coding region only (CDS) and coding region plus
untranslated regions (CDS+UTRs) by injection of RNA (1, 10, 100, or 1000 pg).
The top panel shows a western blot of GDF-3 protein and panels 2-5 show RTPCR on the animal caps. The following markers were used: Sox2 (neural), Msx1
(epidermal marker), BU (mesodermal marker), and ODC (loading control). Lanes
1,2 show whole embryo (st 11) with and without reverse transcription as positive
and negative controls for each RT-PCR marker, respectively. Lane 3 shows an
uninjected control. (B) Morphology of animal caps that were uninjected (left
middle, indicated ‘(-)’), injected with Noggin (a control BMP inhibitor, indicated
‘nog’) or a dose range of GDF-3 CDS (middle column) or CDS+UTRs (right
column). An intact stage 17 embryo is shown in the upper left corner as a stagematched control. Scale bar is 1 mm. (C) Luciferase assay (arbitrary units) using
an Activin/Nodal responsive element (ARE) or a BMP responsive element (BRE)
driving luciferase reporters (Lux). A dose range of each GDF-3 construct (CDS
or CDS+UTRs) was tested against the ARE-Lux alone or against the BRE-Lux
together with BMP4 RNA (100 pg). Lanes 1 and 10 show reporter alone
controls. Lane 11 shows BMP4 RNA alone as a positive control for BRE-Lux
activation. (D) Over-expression of GDF-3 CDS+UTRs with or without α-amanitin.
Lane 1 shows stage 6 as a negative control for Smad phosphorylation
(Phospho-Smad1 and Phospho-Smad2) because the Smad pathways are not
active at this stage. Tubulin is shown as a loading control.
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Figure 29
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I confirmed the effects of a dose range of the coding region plus UTRs
using a luciferase assay. I tested the effects of this construct on activation of a
luciferase gene regulated by a BMP-responsive element (BRE) and an
Activin/Nodal responsive element (ARE). These experiments showed that even
1 pg of the GDF-3 coding region plus UTRs is sufficient for BMP inhibition, while
100 pg -1 ng is required to activate Nodal-like signaling (Figure 29C). To
determine whether this type of activity switching dose response is a common
feature of Nodal-like ligands, I tested the luciferase response to a similar dose
curve using a known Nodal-like ligand, Xnr1. Xnr1 was not able to inhibit BMP
signaling at low doses. 1 ng of Xnr1 mRNA activated the ARE luciferase and
inhibited the BRE luciferase, most likely indirectly through induction of BMP
inhibitors in dorsal mesoderm (data not shown).
I next sought to determine whether GDF-3 switches activity at a certain
dose threshold or acquires Nodal-like activity while retaining the ability to inhibit
BMP signaling. To do this, I analyzed the effects of over-expressing 1 ng (high
dose) of GDF-3 coding region plus UTRs with or without α-amanitin, an inhibitor
of translation that prohibits indirect effects of manipulating signal transduction
pathways. This approach allowed me to observe the primary effects of GDF-3,
but not secondary effects mediated by new transcription. This is important
because activation of Nodal signaling induces dorsal mesoderm, which then
expresses new transcripts of BMP inhibitors such as Noggin and Chordin, and
thus includes primary mesoderm induction and secondary BMP inhibition. I
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found that a high dose of GDF-3 caused inhibition of Smad1/5/8 and direct
activation of Smad2/3 in either the absence or presence of α-amanitin (Figure
29D). Therefore, I showed that GDF-3 is a Smad1/5/8 inhibitor throughout its
dose range and that, at high doses, this activity is coincident with Smad2/3
activation.

5.4 - GDF-3 protein interacts physically with various factors in the TGF-β
pathway
While I detected GDF-3 interaction with BMP4, I also observed that GDF3 can interact with a Nodal like ligand and with xVg1, but not with Activin.
However, neither my data, nor those of Chen and colleagues describe
endogenous protein interactions. Therefore, both sets of data could reflect
promiscuous or artificial binding.

5.5 - The expression of GDF-3 in the early mouse embryo
The different findings on mRNA spatial localization in the mouse embryo,
between my findings and those of Chen and colleagues, can probably be
explained by the use of different in situ probes. We both detected GDF-3 in the
inner cell mass, but observed different patterns in post-implantation stages.
Chen and colleagues used the full-length anti-sense RNA as a probe, whereas I
used the 3’ 500 bp of the coding region to produce the anti-sense probe.
However, I used RT-PCR to confirm the temporal expression pattern of GDF-3,
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and detected the highest signal at e8.5, when Chen and colleagues report no
expression of GDF-3. Further, I performed LacZ staining on genetrap
heterozygous embryos, providing an independent strategy for confirming GDF-3
expression in the notochord.

5.6 - The required roles of GDF-3 in early development
The phenotype of the GDF-3 genetrap allele resembles the gross
morphology of the exon 2 knockout, described by Chen and colleagues.
However, it is important to note striking molecular differences. While the
knockout displays failure to induce (or proper migration of) anterior visceral
endoderm, I found that this tissue is normal. In addition, the knockout has
defects in mesoderm and definitive endoderm induction, while I observed proper
induction of the primitive, node, notochord, heart, and foregut.
One explanation for the different findings could be that the genetrap allele
reduces, but does not remove the wild-type GDF-3 allele, whereas the knockout
is a true loss-of-function. As such, the genetrap may allow minimal, but sufficient
levels of wild-type GDF-3 to be expressed during the establishment of anterior
visceral endoderm and induction of mesendoderm, allowing the genetrap
mutants to perform these steps properly, while the knockout fails to do so.
However, higher levels of GDF-3 may be required for morphogenesis, causing
this process to be perturbed in the genetrap.
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It is also possible that the knockout phenotype reflects earlier failure to
regulate the BMP pathway. Enhanced BMP signaling has been shown to perturb
anterior visceral endoderm induction (Soares et al., 2005), but it is difficult to
understand how elevated Smad1/5/8 activity could block mesoderm formation.
I compared the GDF-3 genetrap phenotype to Nodal pathway mutants in
Chapter 4, and note that a critical difference is that the node and notochord are
induced normally in the genetrap mutant embryos, but do not form in embryos
with reduced Nodal signaling. This latter defect results in a distinct phenotype
from either the GDF-3 genetrap or the GDF-3 exon 2 knockout.

5.7 - GDF-3 is an endogenous BMP inhibitor
Despite some evidence for the ability of GDF-3 to act like Nodal, I feel
that this is probably an artifact of high levels of over-expression of GDF-3. The
real question in studying this potential model is whether the BMP inhibitory and
Nodal-like activating roles for GDF-3 are physiological. I first characterized the
activity of GDF-3 protein because over-expression of RNA or DNA of other TGFβ ligands could yield artificial results. These experiments demonstrated that
GDF-3 mature protein is a BMP inhibitor (Figure 8).
I also studied the endogenous role of GDF-3 in regulating TGF-β
signaling. To do this, I characterized the activation state of the BMP pathway
(through Smad1/5/8 phosphorylation) and TGF-β/Activin/Nodal pathway
(through Smad2/3 phosphorylation) in mouse embryonic stem cells that contain
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a genetrap insertion, interrupting the GDF-3 gene. I found that in steady-state,
cells with reduced GDF-3 levels had slightly increased Smad1/5/8 activation with
no difference in Smad2/3 signaling. Exogenous BMP signaling accentuated this
effect, such that cells with reduced GDF-3 levels had notably higher Smad1/5/8
signaling (Figure 9). As Nodal signaling is only activated by the highest doses of
GDF-3 mRNA, reduction of GDF-3 levels should impinge on this activity first.
However, these data show that GDF-3 is a physiological BMP inhibitor and do
not reveal any endogenous role in activating the Nodal pathway.
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CHAPTER 6: DISCUSSION AND CONCLUSIONS

This thesis work used comparative embryology to study the regulation of
early developmental processes by the TGF-β superfamily, with a focus on the
unusual GDF-3 ligand. Through biochemistry, gain-of-function, and reduction-offunction approaches in multiple developmental contexts, I have created the first
comprehensive analysis of GDF-3 embryonic function.
My data show that GDF-3 is an inhibitory ligand, interacting with and
blocking classic BMP/GDF ligands. Through this mechanism, GDF-3 induces a
secondary dorsal axis in the frog embryo, and acts as a direct neural inducer in
the frog ectoderm. In embryonic stem cells, GDF-3 opposes BMP activity to
regulate the balance between stemness and differentiation. Within the context of
the mouse embryo, GDF-3 is required for normal morphogenesis of the
notochord and dorso-ventral patterning of the body plan. In addition to my
specific findings on the GDF-3 ligand, my work provides the basis for several
general concepts and conclusions.
First, my findings represent a special example of the high degree of
evolutionary conservation of developmental modules. The ability of GDF-3 to
elicit a secondary dorsal axis in the frog embryo relies on the formation of a
molecular equivalent to Spemann’s organizer at the ventral site of injection.
Local BMP inhibition in the ventral body dorsalizes the local mesoderm to
include notochord and paraxial mesoderm, and concomitantly induces neural
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tissue. Together, these tissues constitute the secondary axis (Figure 30A). The
phenotype that I observed in the GDF-3 genetrap mutant mouse embryos
echoes this phenomenon. Through mis-placement of the notochord, the final
derivative of the organizer, the entire dorsal axis is mislocalized, including the
notochord, neural tube, and paraxial mesoderm (Figure 30B). However, ventral
and lateral cell fates such as endoderm and heart, are not perturbed and
maintain their typical location. This reflects the continuing role of the organizer
derivatives in establishing and patterning the dorsal axis.
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Figure 30

Figure 30: The organizer directs formation of the dorsal axis in multiple
contexts. (A) depicts the formation of a double axis by transplantation of an
organizer graft to the ventral side of a host frog embryo, from Figure 23
(Spemann and Mangold, 1924). The graft formed a secondary notochord
(maroon) and induced a secondary neural tube (blue) on the right. (B) shows the
arrangement of the dorsal axis (notochord (maroon), neural tube (blue) in the
GDF-3 genetrap mouse mutants with the lateral/ventral tissues in yellow.
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Interestingly, in embryonic stem cells, GDF-3 contributes to a molecular
pattern that is similar to that of the organizer and its derivatives: including BMP
inhibition, Nodal activation, and possibly IGF activation, although Wnt signaling
is inhibited by the organizer, and active in embryonic stem cells ((Bendall et al.,
2007; James et al., 2005; Pera et al., 2001; Sato et al., 2004; Vincent et al.,
2003), reviewed in (Brivanlou and Levine, 2007; Harland and Gerhart, 1997;
Levine and Brivanlou, 2007). It is not clear whether this is a coincidence, or
whether it could reflect a co-option by embryonic stem cells of a molecular
program that allows the organizer to give rise to derivatives of all three germ
layers, albeit in a more limited manner (Beddington, 1994; Mangold, 1933).
Together, these data demonstrate a recurring theme of molecular embryology –
that after the original establishment of signaling centers and transcriptional
networks for a given role, this module may be ‘re-used’ in both conserved and
independent contexts.
Many of my observations demonstrate that GDF-3 activity in a given cell
type or tissue is opposite to that of published reports for BMP. As such, it is
possible to limit a view of this unusual TGF-β ligand to that of a decoration on
the elaborately regulated BMP pathway and to limit my conclusions to
supporting, in negative and inhibitory form, models about a positive, activating
pathway. However, as the critical example of ‘neural default’ demonstrates,
negative information can be just as important in cell-cell communication as
positive signaling. In contrast to this limited view, I consider that GDF-3 and
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BMPs are opposite poles of an axis – what is typically described as the ‘BMP’
pathway. As such, inhibition of BMPs by GDF-3 and other factors in embryonic
stem cells helps to endow them with ‘stemness.’ Further, my findings regarding
the required role of GDF-3 for normal morphogenesis of the mouse embryo
extends beyond known functions for BMP signaling and furthers our
understanding of the overall function of this GDF-3-BMP axis in regulating early
embryonic development.
Third, my work highlights the remarkable specialization of large families of
factors, here of the TGF-β superfamily into multiple activating branches and
inhibitory branches. Further, my findings on GDF-3 may be informative about
general mechanisms of inhibitory ligands, including LeftyA, LeftyB, BMP3, Xnr3,
BMP15, and GDF9. An important outstanding question is whether there are
distinct qualities of TGF-β inhibition, provided by ligand-inhibitors versus nonligand inhibitorys, such as Noggin and Chordin. This concept is suggested by my
finding that GDF-3 is co-expressed with other BMP inhibitors such as Noggin
and Chordin; however, removal of GDF-3 perturbs cell movement, while removal
of both Noggin and Chordin affect cell fate. If GDF-3 is representative of
inhibitory-ligands, my work provides a basis for understanding the mechanisms
of nearly one sixth of the ligands in the TGF-β superfamily. Therefore, my
findings contribute to an integrated understanding of this pathway during early
vertebrate embryogenesis.
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MATERIALS AND METHODS:

Xenopus Embryos and Explants:
Embryos were obtained and manipulated as previously described (HemmatiBrivanlou et al., 1989) and staged as described in Niewkoop and Faber (1967).
Embryo explants (animal caps, ventral and dorsal marginal zones) were isolated
in 0.1X MMR, washed once and transferred immediately to 0.5X MMR with
gentamycin for culture. For animal cap disassociation, caps were isolated in
CMFM media (88mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 5 mM HEPES). Cut
caps were transferred to fresh CMFM with 0.5% BSA in an agarose coated dish
for several minutes with the sensorial layer down, to allow the epithelial layer to
peel away; this step was aided with a hair knife. Disassociated cap cells were
then transferred to 100 ul/well of CMFM/BSA in pre-coated 96-well plates for
protein co-culture for four hours. During culture, cells were mixed every thirty
minutes by pipetting. Cells were then transferred to a pre-BSA-coated eppendorf
tube containing 0.75X MMR and 10 mM Ca2+/Mg2+ and spun at 800 rpm for two
minutes to reaggregate the cells. The cell pellet was then cultured until sibling
embryos reached stage 11.5 and harvested for mRNA. Staging was determined
using sibling embryos.
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Cell Culture:
Human embryonic stem cells were maintained in conditioned medium produced
by mouse embryonic fibroblasts. The media is DMEM/F12 with 20% KSR,
pencillin/streptomycin, 2 mM L-glutamine, 1X non-essential amino acids, 55 µM
β-mercaptoethanol, and FGF (4 ng/mL). 10 ng/mL of recombinant human BMP4
(rhBMP4) (R&D) or 1 ug/mL of recombinant human GDF-3 (Peprotech) was
used for treatments. P19 cells were maintained in MEM-α-modified media
(Sigma) with 7.5% CBS, 2.5% FBS. C2C12 cells were maintained in DMEM
(Sigma) with 15% FBS. For differentiation of C2C12 cells, cells were grown to
confluence, changed to DMEM with 2% serum and BMP4 (100 ng/mL) or TGFβ1 (R&D) (1 ng/mL) was added. Genetrap ES cells (The Wellcome Trust Sanger
Institute) parent strain 12901a and genetrap AD0857 cells were cultured on
gelatin with 1400 U LIF/mL in 1X GMEM containing 10% FBS, 2 mM l-glutamine,
1 mM sodium pyruvate, 1X non-essential amino acids, and 55 µM βmercaptoethanol. New genetrap mouse embryonic stem cells were derived by
allowing blastocysts to attach to mouse embryonic fibroblasts (MEFs) grown in
1000 U/mL of LIF and outgrow for three days. Outgrowths were then isolated
with a micropipette, briefly trypsinized, and transferred to new MEFs to
propagate the new line.
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Embryoid Body Formation:
Cells were trypsinized to a single cell suspension, counted, and diluted to
10,000 cells/mL in ES growth media with no LIF. Twenty-five µL droplets of cell
suspension were placed on the lid of a 10 cm bacterial culture dish and cultured
inverted over media for two days. Embryoid bodies were then flushed into EB
media (DMEM with 10% FBS) and cultured for seven days. % EB formation was
assessed by counting the number of embryoid bodies formed/number of droplets
per condition x 100%.

Node explants:

The distal fifth of the embryonic regions of e7.25-e7.5 mouse embryos was
explanted with siliconized glass needles (dipped in sigmacote, as described in
(Nagy et al., 2003)) and transferred to fibronectin-coated (Sigma human plasma
fibronectin at 0.1 mg/mL in PBS for several hours) plastic dishes, with one node
per well. Explants were cultured in human ES media (above) without FGF.
Dissection was performed in the same media, containing 25 mM HEPES pH 7.4.
After 4-5 hours allowed for attachment, divets were created in the plastic
immediately next to each explant and one to four beads were placed in the divet.
Beads (Affigel Blue from BioRad) were washed twice in PBS, then soaked in
rhBMP4 or human serum albumin (final concentration 5 ug/mL) for two hours at
37 °C, then washed twice and placed into the divet. A pre-wetted plastic or glass
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coverslip was placed on top to prevent the beads from moving out of the divet.
After 48 hours, the explants were fixed, and nuclei were stained with Sytox
orange (1:25,000) for visualization.

RT-PCR:
For Xenopus, ten animal caps or one embryo were isolated. For mouse, five preimplantation embryos, three gastrulation stage embryos, or one post-gastrulation
stage embryo were used. For real-time PCR The following primers were used.
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Table 2: RT-PCR primers

PRIMER
MARKER
SENSE
ANTISENSE
hB-actin
housekeeping gene TGGCACCACACCTTCTACAATGAGC
GCACAGCTTCTCCTTAATGTCACG
hCdx2-RT Trophoblast
TGGAGCTGGAGAAGGAGTTTCACT
CTCCTTTGCTCTGCGGTTCTGAAA
hNanog
stem cell
ACCAGAACTGTAGGGGGAAA
GGTTGCTCCAGGTTGAATTGTTCC
hOct4
stem cell
GAAGGATGTGGTCCGAGTGT
GTGACAGAGACAGGGGGAAA
hSox2
stem cell/neural
ACCAGCTCGCAGACCTACAT
GGTAGTGCTGGGACATGTGA
hTbp1-RT housekeeping gene GCTGGCCCATAGTGATCTTT
CTTCACACGCCAAGAAACAGT
mAFP
Endoderm
ATTCCTTCTTCATGCCAG
ACACGTCCCCATCTGAAG
mB-actin housekeeping gene GGCCCAGAGCAAGAGAGGTATCC
ACGCACGATTTCCCTCTCAGC
mBU
Mesendoderm
GCTGTGACTGCCTACCAGCAGAATG
GAGAGAGAGCGAGCCTCCAAAC
mFGF5
Epiblast
AAAGTCAATGGCTCCCACGAA
CTTCAGTCTGTACTTCACTGG
mFlk1
Endothelium
CACCTGGCACTCTCCACCTTC
GATTTCATCCCACTACCGAAAG
mGDF-3
gene of interest
CACTTGATTAGCTCCCAGGC
TCTGGAGACAGGAGCCATCT
mHPRT
housekeeping gene GCTGGTGAAAAGGACCTCT
CACAGGACTAGAACAACCTGC
mNkx2.5 Heart
TGCAGAAGGCAGTGGAGCTGGACAAGCC TGCACTTGTAGCGACGGTTCTGG
mOct4
stem cell
GGCGTTCTCTTTGGAAAGGTGTTC
CTCGAACCACATCCTTCTCT
mPax6
anterior neural/eye GCTTCATCCGAGTCTTCTCCGTTAG
CCATCTTGCTTGGGAAATCCG
mRax
anterior neural
GAGTTGCTGCGAGCCCTGTGT
CCGATGATAGGCGCTGATGCT
mScl-1
Blood
ATTGCACACACGGGATTCTG
GAATTCAGGGTCTTCCTTAG
mSox2
stem cell/neural
GGCAGCTACAGCATGATGCAGG
CTGGTCATGGAGTTGTACTGC
xGlobin
Blood
CAGGCTGGTGAGCTGCCC
GCCTACAACCTGAGAGTGG
xBU
Mesoderm
GGATCGTTATCACCTCTG
GTGTAGTCTGTAGCAGCA
xCollagen II Notochord
GGATTCAAGGACTCTAGTGC
GATCTCAGCATTGGGGCAAT
xM-actin
Muscle
GCTGACAGAATGCAGAAG
TTGCTTGGAGTGTGT
xMsx1
epidermis
ACTGGTGTGAAGCCGTCCCT
TTCTCTCGGGACTCTCAGGC
xNCAM
neural
AGATGCAGTCATTATTTGTGATGTC
CTGGATGTCCTTATAGTTGATCTC
xODC
housekeeping gene AATGGATTTCAGAGACCA
CCAAGGCTAAAGTTGCAG
xOtx2
neural
GGAGGCCAAAACAAAGTG
TCATGGGGTAGGTCCTCT
xSox2
neural
CAGGAGGAAAACCAACC
TGGGGGTATCCAAGCTGCTC
xWnt8
ventral mesoderm GTTCAAGCATTACCCCGGAT
CTCCTCAATTCCATTCTGCG
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Luciferase Assays:
All luciferase assays were done in three separate experiments, each in triplicate;
representative individual triplicate experiments are shown in the results section.
In Xenopus embryos, 20 pg of luciferase DNA construct (BRE-Lux or ARE-Lux)
was injected into the animal region of two cell embryos together with the
indicated RNAs transcribed from constructs in pCS2++. Pools of four embryos
were harvested at stage 11 in 50 µL of lysis buffer. In P19 cells, cells were
transfected with 150 ng of reporter, 3.3 ng of renilla reporter, 0.25 µg of Smad1
and Smad4 (each), 0.1 µg of OAZ and test constructs in pCS2++ or empty
vector for a total of 1.6 µg/well. After six hours of transfection, media was
changed to MEM-α-modified media with 0.2% serum. After 32 hours, cells were
lysed in 150 µL of lysis buffer and analyzed for luciferase activity. The error bars
indicate standard deviation.

Immunoprecipitations and Western Blots:
Immunoprecipitations on over-expressed proteins were performed as previously
described (Yeo and Whitman, 2001) with mαFlag (Sigma; 1 ul/sample) or mαHA
(Babco; 5 ul/sample). Antibodies used in western blots were mαα-tubulin
(Sigma; 1:1000); rαcyclophillinB (Affinity BioReagents; 1:2000); mαSmad1
(Santa Cruz; 1:750); mαSmad2 (BD Biosciences; 1:750); rαP-Smads (Cell
Signaling; 1:1000); mαOct3 (BD Transduction Laboratories; 1:1000);
mαTROMA-1 (Dev Studies Hybridoma Bank; 1:75); gαGDF-3 (R&D; 1:10,000);
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mαFlag (Sigma; 1:10,000); mαHA (Covance; 1:1000). Mα indicates mouse
monoclonal antibody; rα and gα indicate rabbit and goat polyclonal antibody,
respectively.

In situ Hybridization:
Whole mount in situ hybridization was performed as described (Merrill et al.,
2004). Probes were prepared from GDF-3 in pCS2++ (anti-sense Pst1/T3; fulllenth sense Not1/Sp6). Sectioning of whole mount embryos was performed with
10 µm cryosections after embedding in OCT. Section in situ hybridizations were
performed on adult Swiss Webster male testis and was performed as in
Rouzankina et al., 2004 except that hybridization was performed by dipping
slides into solution.

Immunofluorescence:
Immunofluoresence (IF) on testis was carried out on 10 µm frozen sections postfixed in 4% paraformaldehyde (PFA). IF on sperm was carried out on sperm
dissected from the cauda epididymis that was teased apart and incubated at
37°C for one hour, after which the supernatant was passed over a cell sorter
screen to remove any debris. The sperm were then added in solution to a well
containing a poly-L-lysine coated coverslip, spun at 450 xg, fixed in 4% PFA
(added 1:1 as 8% PFA), and respun at 450xg for ten minutes. IF on blastocyst
embryos was done after fixation for 15 minutes in 4% PFA. All IF samples were
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washed in PBS containing 0.25% BSA, blocked and permeabilized in 10%
donkey serum with 3% Triton, and incubated in primary antibody gαGDF-3
(R&D) (1:500 for sections, 1:100 for sperm) in 10% donkey serum for three
hours at room temperature. Testis control samples were incubated with 1:500
primary antibody pre-incubated with recombinant mouse GDF-3 peptide (R&D)
at a five times molar excess. Samples were then washed and incubated in
secondary antibody then counterstained with either SytoxGreen (Molecular
Probes) for nuclear stain or with peanut agglutinin (PNA) (Vector Laboratories)
for acrosomal stain.

LacZ staining:
Embryos were dissected in cold PBS and fixed for 15 minutes on ice in fixation
buffer (0.1M phosphate buffer pH 7.3, 0.2% gluteraldehyde, 5 mM EGTA, 2 mM
MgCl2). Embryos were then washed three times 15-30 minutes each (0.1M
phosphate buffer pH 7.3, 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP40), and stained at 37°C (wash buffer, including 5 mM K3Fe, 5 mM K4Fe, 20 mM
Tris pH 7.3, 1 mg/mL Red-GAL). Staining of Chd-rtTA/TEToLacZ embryos took
0.5-2 hrs, staining of GDF-3 genetrap embryos took 2 days.

Constructs:
The coding region of GDF-3 and the coding region of GDF-3 plus UTRs were
generously provided by S.J. Lee and R.M. Harland, respectively. They were both
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subcloned into the EcoR1/Not1 sites of pCS2++. For sense RNA, GDF-3 was
linearized with Not1 and transcribed with SP6. The cleavage mutant of GDF-3
(coding region alone) in pCS2++ was produced by site-directed mutagenesis
with the Stratagene QuickChange kit using the following primers:
CATCCTTCTTCCGGAAACGTGGGGGCGGCCATCTCTGTCCCC (sense) and
GGGGACAGAGATGGCCGCCCCCACGTTTCCGGAAGAAGGATG (antisense). The amino acid coding was converted from RKRR to GNVG. BMP4
untagged is in pSP64T and RNA was produced with EcoR1/SP6. BMP4-HA was
produced with AvrII/T7. ActivinB-HA is in pCS2++ and was produced with
Not1/SP6. Vg1-HA (provided by S. Cheng) is in pcDNA3.1 and was produced
with AvrII/T7. xNR1 is in pCS2++ and was produced with Not1/SP6.
Recombinant human GDF-3 protein was purchased from Peprotech.
Recombinant mouse Nodal protein was purchased from R&D Systems.

Genetrap Mouse Genotyping
Tail tips or embryos were lysed in 750 or 200 ul of SNET buffer (20 mM Tris-HCl
pH 8.0, 5 mM EDTA pH 8.0, 400 mM NaCl, 1% SDS) containing 400 ug/mL
Proteinase K overnight at 55°. An equal volume of phenol/chloroform/isoamyl
alcohol was then added, samples were shaken for 30 seconds, and samples
were rotated for 30 minutes. The aqueous phase was then isolated and a final
concentration of 0.2M NaCl and 70% ethanol was added to precipitate genomic
DNA without SDS. Precipitated genomic DNA (gDNA) was washed once with

140

70% ethanol and gDNA from tail tips was resuspended in 300 ul of TE and
embryo DNA was resuspended in 50 ul of TE and samples were allowed to
resuspend at room temperature for at least three hours. 1 ul of tail tip gDNA or 5
ul of embryo gDNA was used in each PCR reaction. All PCR reactions were
performed in duplicate and were only considered if the cycle number that passed
an arbitrary threshold (ΔCT) for each sample was within 1 cycle (but duplicates
were usually less than 0.3 cycles apart). Genotyping was performed using three
pairs of primers: LacZ, intron boundary (5770-5892), and a normal two-copy
gene (Wnt2b). The LacZ and Wnt2b primer sequences were taken from a
genotyping strategy at Regeneron.
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Table 3

PRIMER
LacZ
5770-5892 “D”
Wnt2b
Chd-rtTA
TRE-BMP4
TRE-DTA

SENSE

ANTISENSE

GGAGTGCGATCTTCCTGAGG

CGCATCGTAACCGTGCATC

AGCCAAGGCTAGACAGAGAA

GGTCAGCATCAGCTTCCTCTTCAA

GCAGCTGTGACCCATATACCC

CACTACAGCCACCCCAGTCAA

TCCGCGTCCAATTCACCATGTCTA

AGTTTCCTTGTCGTCAGGCCTTC

TTAGTGAACCGTCAGATCGCCT

TCCCGGTCTCAGGTATCAAACT

TTAGTGAACCGTCAGATCGCCT

TAACCAGGTTTAGTCCCGTGGT

142

REFERENCES
Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P. W.,
Beighton, G., Bello, P. A., Benvenisty, N., Berry, L. S., Bevan, S. et al. (2007).
Characterization of human embryonic stem cell lines by the International Stem Cell
Initiative. Nat Biotechnol 25, 803-16.
Agius, E., Oelgeschlager, M., Wessely, O., Kemp, C. and De Robertis, E. M. (2000).
Endodermal Nodal-related signals and mesoderm induction in Xenopus. Development
127, 1173-83.
Anderson, R. M., Lawrence, A. R., Stottmann, R. W., Bachiller, D. and
Klingensmith, J. (2002). Chordin and noggin promote organizing centers of forebrain
development in the mouse. Development 129, 4975-87.
Andersson, O., Reissmann, E., Jornvall, H. and Ibanez, C. F. (2006). Synergistic
interaction between Gdf1 and Nodal during anterior axis development. Dev Biol 293,
370-81.
Ang, S. L. and Rossant, J. (1994). HNF-3 beta is essential for node and notochord
formation in mouse development. Cell 78, 561-74.
Aono, A., Hazama, M., Notoya, K., Taketomi, S., Yamasaki, H., Tsukuda, R.,
Sasaki, S. and Fujisawa, Y. (1995). Potent ectopic bone-inducing activity of bone
morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 210, 670-7.
Ariizumi, T., Sawamura, K., Uchiyama, H. and Asashima, M. (1991). Dose and
time-dependent mesoderm induction and outgrowth formation by activin A in Xenopus
laevis. Int J Dev Biol 35, 407-14.
Bachiller, D., Klingensmith, J., Kemp, C., Belo, J. A., Anderson, R. M., May, S. R.,
McMahon, J. A., McMahon, A. P., Harland, R. M., Rossant, J. et al. (2000). The
organizer factors Chordin and Noggin are required for mouse forebrain development.
Nature 403, 658-61.
Bachiller, D., Klingensmith, J., Shneyder, N., Tran, U., Anderson, R., Rossant, J.
and De Robertis, E. M. (2003). The role of chordin/Bmp signals in mammalian
pharyngeal development and DiGeorge syndrome. Development 130, 3567-78.
Beattie, G. M., Lopez, A. D., Bucay, N., Hinton, A., Firpo, M. T., King, C. C. and
Hayek, A. (2005). Activin A maintains pluripotency of human embryonic stem cells in
the absence of feeder layers. Stem Cells 23, 489-95.
Beddington, R. S. (1994). Induction of a second neural axis by the mouse node.
Development 120, 613-20.
143

Bendall, S. C., Stewart, M. H., Menendez, P., George, D., Vijayaragavan, K.,
Werbowetski-Ogilvie, T., Ramos-Mejia, V., Rouleau, A., Yang, J., Bosse, M. et al.
(2007). IGF and FGF cooperatively establish the regulatory stem cell niche of
pluripotent human cells in vitro. Nature 448, 1015-21.
Brickman, J. M., Jones, C. M., Clements, M., Smith, J. C. and Beddington, R. S.
(2000). Hex is a transcriptional repressor that contributes to anterior identity and
suppresses Spemann organiser function. Development 127, 2303-15.
Brivanlou, A. H. and Darnell, J. E., Jr. (2002). Signal transduction and the control of
gene expression. Science 295, 813-8.
Brivanlou, A. H., Gage, F. H., Jaenisch, R., Jessell, T., Melton, D. and Rossant, J.
(2003). Stem cells. Setting standards for human embryonic stem cells. Science 300, 9136.
Brivanlou, A. H. and Levine, A. J. (2007). Molecular Basis of Pluripotency. In
Principles of Regenerative Medicine, (ed. A. Atala R. Lanza R. Nerem and J. Thomson):
Elsevier Academic Press.
Burdsal, C. A., Damsky, C. H. and Pedersen, R. A. (1993). The role of E-cadherin
and integrins in mesoderm differentiation and migration at the mammalian primitive
streak. Development 118, 829-44.
Camus, A., Perea-Gomez, A., Moreau, A. and Collignon, J. (2006). Absence of
Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev
Biol 295, 743-55.
Candia, A. F., Watabe, T., Hawley, S. H., Onichtchouk, D., Zhang, Y., Derynck, R.,
Niehrs, C. and Cho, K. W. (1997). Cellular interpretation of multiple TGF-beta signals:
intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by
Smads. Development 124, 4467-80.
Chen, C., Ware, S. M., Sato, A., Houston-Hawkins, D. E., Habas, R., Matzuk, M.
M., Shen, M. M. and Brown, C. W. (2006). The Vg1-related protein Gdf3 acts in a
Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 133, 31929.
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B.
and Robertson, E. J. (1994). A primary requirement for nodal in the formation and
maintenance of the primitive streak in the mouse. Development 120, 1919-28.
Coucouvanis, E. and Martin, G. R. (1999). BMP signaling plays a role in visceral
endoderm differentiation and cavitation in the early mouse embryo. Development 126,
535-46.

144

Daheron, L., Opitz, S. L., Zaehres, H., Lensch, W. M., Andrews, P. W., ItskovitzEldor, J. and Daley, G. Q. (2004). LIF/STAT3 signaling fails to maintain self-renewal
of human embryonic stem cells. Stem Cells 22, 770-8.
Dale, L., Howes, G., Price, B. M. and Smith, J. C. (1992). Bone morphogenetic
protein 4: a ventralizing factor in early Xenopus development. Development 115, 57385.
Di-Gregorio, A., Sancho, M., Stuckey, D. W., Crompton, L. A., Godwin, J.,
Mishina, Y. and Rodriguez, T. A. (2007). BMP signalling inhibits premature neural
differentiation in the mouse embryo. Development.
Dosch, R., Gawantka, V., Delius, H., Blumenstock, C. and Niehrs, C. (1997). Bmp-4
acts as a morphogen in dorsoventral mesoderm patterning in Xenopus. Development
124, 2325-34.
Dufort, D., Schwartz, L., Harpal, K. and Rossant, J. (1998). The transcription factor
HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis.
Development 125, 3015-25.
Dunn, N. R., Vincent, S. D., Oxburgh, L., Robertson, E. J. and Bikoff, E. K. (2004).
Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and
patterning in the mouse embryo. Development 131, 1717-28.
Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiowaara,
K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M. et al. (1996).
GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789-93.
Eimon, P. M. and Harland, R. M. (2002). Effects of heterodimerization and proteolytic
processing on Derriere and Nodal activity: implications for mesoderm induction in
Xenopus. Development 129, 3089-103.
Graff, J. M., Bansal, A. and Melton, D. A. (1996). Xenopus Mad proteins transduce
distinct subsets of signals for the TGF beta superfamily. Cell 85, 479-87.
Graff, J. M., Thies, R. S., Song, J. J., Celeste, A. J. and Melton, D. A. (1994). Studies
with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override
dorsal signals in vivo. Cell 79, 169-79.
Green, J. B., New, H. V. and Smith, J. C. (1992). Responses of embryonic Xenopus
cells to activin and FGF are separated by multiple dose thresholds and correspond to
distinct axes of the mesoderm. Cell 71, 731-9.
Green, J. B. and Smith, J. C. (1990). Graded changes in dose of a Xenopus activin A
homologue elicit stepwise transitions in embryonic cell fate. Nature 347, 391-4.

145

Gritsman, K., Zhang, J., Cheng, S., Heckscher, E., Talbot, W. S. and Schier, A. F.
(1999). The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97,
121-32.
Groppe, J., Greenwald, J., Wiater, E., Rodriguez-Leon, J., Economides, A. N.,
Kwiatkowski, W., Affolter, M., Vale, W. W., Belmonte, J. C. and Choe, S. (2002).
Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature
420, 636-42.
Grunz, H. and Tacke, L. (1989). Neural differentiation of Xenopus laevis ectoderm
takes place after disaggregation and delayed reaggregation without inducer. Cell Differ
Dev 28, 211-7.
Hamatani, T., Daikoku, T., Wang, H., Matsumoto, H., Carter, M. G., Ko, M. S. and
Dey, S. K. (2004). Global gene expression analysis identifies molecular pathways
distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci U S A 101,
10326-31.
Haramoto, Y., Tanegashima, K., Onuma, Y., Takahashi, S., Sekizaki, H. and
Asashima, M. (2004). Xenopus tropicalis nodal-related gene 3 regulates BMP signaling:
an essential role for the pro-region. Dev Biol 265, 155-68.
Harland, R. and Gerhart, J. (1997). Formation and function of Spemann's organizer.
Annu Rev Cell Dev Biol 13, 611-67.
Harland, R. M. (2004). Dorsoventral Patterning of the Mesoderm. In Gastrulation:
From Cells to Embryos, (ed. C. D. Stern), pp. 373-388. Cold Spring Harbor, NY: Cold
Spring Harbor Laboratory Press.
Hata, A., Lagna, G., Massague, J. and Hemmati-Brivanlou, A. (1998). Smad6
inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor
suppressor. Genes Dev 12, 186-97.
Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A. and
Massague, J. (2000). OAZ uses distinct DNA- and protein-binding zinc fingers in
separate BMP-Smad and Olf signaling pathways. Cell 100, 229-40.
Hemmati-Brivanlou, A., Kelly, O. G. and Melton, D. A. (1994). Follistatin, an
antagonist of activin, is expressed in the Spemann organizer and displays direct
neuralizing activity. Cell 77, 283-95.
Hemmati-Brivanlou, A. and Melton, D. A. (1992). A truncated activin receptor
inhibits mesoderm induction and formation of axial structures in Xenopus embryos.
Nature 359, 609-14.

146

Hemmati-Brivanlou, A. and Melton, D. A. (1994). Inhibition of activin receptor
signaling promotes neuralization in Xenopus. Cell 77, 273-81.
Hemmati-Brivanlou, A. and Thomsen, G. H. (1995). Ventral mesodermal patterning
in Xenopus embryos: expression patterns and activities of BMP-2 and BMP-4. Dev
Genet 17, 78-89.
Hemmati-Brivanlou, A., Wright, D. A. and Melton, D. A. (1992). Embryonic
expression and functional analysis of a Xenopus activin receptor. Dev Dyn 194, 1-11.
James, D., Levine, A. J., Besser, D. and Hemmati-Brivanlou, A. (2005).
TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in
human embryonic stem cells. Development 132, 1273-82.
Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L.,
Hu, Z., Cupples, R. et al. (1996). GDNF-induced activation of the ret protein tyrosine
kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113-24.
Jones, C. M., Lyons, K. M., Lapan, P. M., Wright, C. V. and Hogan, B. L. (1992a).
DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus
mesoderm induction. Development 115, 639-47.
Jones, C. M., Simon-Chazottes, D., Guenet, J. L. and Hogan, B. L. (1992b). Isolation
of Vgr-2, a novel member of the transforming growth factor-beta-related gene family.
Mol Endocrinol 6, 1961-8.
Joseph, E. M. and Melton, D. A. (1998). Mutant Vg1 ligands disrupt endoderm and
mesoderm formation in Xenopus embryos. Development 125, 2677-85.
Jurand, A. (1974). Some aspects of the development of the notochord in mouse
embryos. J Embryol Exp Morphol 32, 1-33.
Kinder, S. J., Tsang, T. E., Ang, S. L., Behringer, R. R. and Tam, P. P. (2001a).
Defects of the body plan of mutant embryos lacking Lim1, Otx2 or Hnf3beta activity. Int
J Dev Biol 45, 347-55.
Kinder, S. J., Tsang, T. E., Wakamiya, M., Sasaki, H., Behringer, R. R., Nagy, A.
and Tam, P. P. (2001b). The organizer of the mouse gastrula is composed of a dynamic
population of progenitor cells for the axial mesoderm. Development 128, 3623-34.
Korkola, J. E., Houldsworth, J., Chadalavada, R. S., Olshen, A. B., Dobrzynski, D.,
Reuter, V. E., Bosl, G. J. and Chaganti, R. S. (2006). Down-regulation of stem cell
genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo
differentiation of human male germ cell tumors. Cancer Res 66, 820-7.

147

Lander, E. S. Linton, L. M. Birren, B. Nusbaum, C. Zody, M. C. Baldwin, J. Devon,
K. Dewar, K. Doyle, M. FitzHugh, W. et al. (2001). Initial sequencing and analysis of
the human genome. Nature 409, 860-921.
Lawson, K. A., Dunn, N. R., Roelen, B. A., Zeinstra, L. M., Davis, A. M., Wright, C.
V., Korving, J. P. and Hogan, B. L. (1999). Bmp4 is required for the generation of
primordial germ cells in the mouse embryo. Genes Dev 13, 424-36.
Levin, M., Johnson, R. L., Stern, C. D., Kuehn, M. and Tabin, C. (1995). A
molecular pathway determining left-right asymmetry in chick embryogenesis. Cell 82,
803-14.
Levine, A. J. and Brivanlou, A. H. (2006a). GDF3 at the crossroads of TGF-beta
signaling. Cell Cycle 5, 1069-73.
Levine, A. J. and Brivanlou, A. H. (2006b). GDF3, a BMP inhibitor, regulates cell fate
in stem cells and early embryos. Development 133, 209-16.
Levine, A. J. and Brivanlou, A. H. (2007). Proposal of a model of mammalian neural
induction. Dev Biol 308, 247-56.
Lowe, L. A., Yamada, S. and Kuehn, M. R. (2001). Genetic dissection of nodal
function in patterning the mouse embryo. Development 128, 1831-43.
Mangold, O. (1933). Uber die Induktionsfahighkeit der verschiedenen Bezirke der
Neurula von Urodelen. Naturewissenshaften 21, 761-766.
Martinez Barbera, J. P., Clements, M., Thomas, P., Rodriguez, T., Meloy, D.,
Kioussis, D. and Beddington, R. S. (2000). The homeobox gene Hex is required in
definitive endodermal tissues for normal forebrain, liver and thyroid formation.
Development 127, 2433-45.
Martinez-Barbera, J. P. and Beddington, R. S. (2001). Getting your head around Hex
and Hesx1: forebrain formation in mouse. Int J Dev Biol 45, 327-36.
McMahon, J. A., Takada, S., Zimmerman, L. B., Fan, C. M., Harland, R. M. and
McMahon, A. P. (1998). Noggin-mediated antagonism of BMP signaling is required for
growth and patterning of the neural tube and somite. Genes Dev 12, 1438-52.
Munoz-Sanjuan, I., Bell, E., Altmann, C. R., Vonica, A. and Brivanlou, A. H.
(2002). Gene profiling during neural induction in Xenopus laevis: regulation of BMP
signaling by post-transcriptional mechanisms and TAB3, a novel TAK1-binding protein.
Development 129, 5529-40.
Munoz-Sanjuan, I. and Brivanlou, A. H. (2002). Neural induction, the default model
and embryonic stem cells. Nat Rev Neurosci 3, 271-80.
148

Nagy, A., Gertsenstein, M., Vintersten, K. and Behringer, R. R. (2003).
Manipulating the Mouse Embryo. Cold Spring Harbor, NY: Cold Spring Harbor
Laboratory Press.
Nakatsuji, N., Snow, M. H. and Wylie, C. C. (1986). Cinemicrographic study of the
cell movement in the primitive-streak-stage mouse embryo. J Embryol Exp Morphol 96,
99-109.
Ninomiya, H., Elinson, R. P. and Winklbauer, R. (2004). Antero-posterior tissue
polarity links mesoderm convergent extension to axial patterning. Nature 430, 364-7.
Pedersen, R. A., Wu, K. and Balakier, H. (1986). Origin of the inner cell mass in
mouse embryos: cell lineage analysis by microinjection. Dev Biol 117, 581-95.
Pera, E. M., Wessely, O., Li, S. Y. and De Robertis, E. M. (2001). Neural and head
induction by insulin-like growth factor signals. Dev Cell 1, 655-65.
Perea-Gomez, A., Vella, F. D., Shawlot, W., Oulad-Abdelghani, M., Chazaud, C.,
Meno, C., Pfister, V., Chen, L., Robertson, E., Hamada, H. et al. (2002). Nodal
antagonists in the anterior visceral endoderm prevent the formation of multiple primitive
streaks. Dev Cell 3, 745-56.
Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A. and Bongso, A. (2000).
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat
Biotechnol 18, 399-404.
Rhinn, M., Dierich, A., Shawlot, W., Behringer, R. R., Le Meur, M. and Ang, S. L.
(1998). Sequential roles for Otx2 in visceral endoderm and neuroectoderm for forebrain
and midbrain induction and specification. Development 125, 845-56.
Robertson, E. J., Norris, D. P., Brennan, J. and Bikoff, E. K. (2003). Control of early
anterior-posterior patterning in the mouse embryo by TGF-beta signalling. Philos Trans
R Soc Lond B Biol Sci 358, 1351-7; discussion 1357.
Rodriguez, S., Jafer, O., Goker, H., Summersgill, B. M., Zafarana, G., Gillis, A. J.,
van Gurp, R. J., Oosterhuis, J. W., Lu, Y. J., Huddart, R. et al. (2003). Expression
profile of genes from 12p in testicular germ cell tumors of adolescents and adults
associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 22, 1880-91.
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. and Brivanlou, A. H. (2004).
Maintenance of pluripotency in human and mouse embryonic stem cells through
activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10,
55-63.

149

Sato, N., Sanjuan, I. M., Heke, M., Uchida, M., Naef, F. and Brivanlou, A. H.
(2003). Molecular signature of human embryonic stem cells and its comparison with the
mouse. Dev Biol 260, 404-13.
Sausedo, R. A. and Schoenwolf, G. C. (1994). Quantitative analyses of cell behaviors
underlying notochord formation and extension in mouse embryos. Anat Rec 239, 103-12.
Shi, Y. and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell
membrane to the nucleus. Cell 113, 685-700.
Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N.,
Irie, K., Nishida, E. and Matsumoto, K. (1996). TAB1: an activator of the TAK1
MAPKKK in TGF-beta signal transduction. Science 272, 1179-82.
Skotheim, R. I., Autio, R., Lind, G. E., Kraggerud, S. M., Andrews, P. W., Monni,
O., Kallioniemi, O. and Lothe, R. A. (2006). Novel genomic aberrations in testicular
germ cell tumors by array-CGH, and associated gene expression changes. Cell Oncol 28,
315-26.
Smith, J. C. (1987). A mesoderm-inducing factor is produced by Xenopus cell line.
Development 99, 3-14.
Smith, W. C. and Harland, R. M. (1992). Expression cloning of noggin, a new
dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70, 82940.
Snow, M. H. L. (1977). Gastrulation in the mouse: growth and regionalization of the
epiblast. J Embryol Exp Morphol 42, 293-303.
Soares, M. L., Haraguchi, S., Torres-Padilla, M. E., Kalmar, T., Carpenter, L., Bell,
G., Morrison, A., Ring, C. J., Clarke, N. J., Glover, D. M. et al. (2005). Functional
studies of signaling pathways in peri-implantation development of the mouse embryo by
RNAi. BMC Dev Biol 5, 28.
Sokol, S., Wong, G. G. and Melton, D. A. (1990). A mouse macrophage factor induces
head structures and organizes a body axis in Xenopus. Science 249, 561-4.
Spemann, H. and Mangold, H. (1924). Uber Induktion von Embryonalanlangen durch
Implantation artfremder Organisatoren. Archiv fur Mikroskopische Anatomie und
Entwikslungsmechanik 100.
Sulik, K., Dehart, D. B., Iangaki, T., Carson, J. L., Vrablic, T., Gesteland, K. and
Schoenwolf, G. C. (1994). Morphogenesis of the murine node and notochordal plate.
Dev Dyn 201, 260-78.

150

Suzuki, A., Thies, R. S., Yamaji, N., Song, J. J., Wozney, J. M., Murakami, K. and
Ueno, N. (1994). A truncated bone morphogenetic protein receptor affects dorsal-ventral
patterning in the early Xenopus embryo. Proc Natl Acad Sci U S A 91, 10255-9.
Tabibzadeh, S. and Hemmati-Brivanlou, A. (2006). Lefty at the crossroads of
"stemness" and differentiative events. Stem Cells 24, 1998-2006.
Takahashi, S., Yokota, C., Takano, K., Tanegashima, K., Onuma, Y., Goto, J. and
Asashima, M. (2000). Two novel nodal-related genes initiate early inductive events in
Xenopus Nieuwkoop center. Development 127, 5319-29.
Thomsen, G., Woolf, T., Whitman, M., Sokol, S., Vaughan, J., Vale, W. and Melton,
D. A. (1990). Activins are expressed early in Xenopus embryogenesis and can induce
axial mesoderm and anterior structures. Cell 63, 485-93.
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A. S., Sieber, B. A., Grigoriou, M.,
Kilkenny, C., Salazar-Grueso, E., Pachnis, V. and Arumae, U. (1996). Functional
receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785-9.
Vallier, L., Alexander, M. and Pedersen, R. A. (2005). Activin/Nodal and FGF
pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci
118, 4495-509.
Vallier, L., Reynolds, D. and Pedersen, R. A. (2004). Nodal inhibits differentiation of
human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 275,
403-21.
Varlet, I., Collignon, J. and Robertson, E. J. (1997). nodal expression in the primitive
endoderm is required for specification of the anterior axis during mouse gastrulation.
Development 124, 1033-44.
Vincent, S. D., Dunn, N. R., Hayashi, S., Norris, D. P. and Robertson, E. J. (2003).
Cell fate decisions within the mouse organizer are governed by graded Nodal signals.
Genes Dev 17, 1646-62.
Vonica, A. and Brivanlou, A. H. (2007). The left-right axis is regulated by the interplay
of Coco, Xnr1 and derriere in Xenopus embryos. Dev Biol 303, 281-94.
Wall, N. A., Craig, E. J., Labosky, P. A. and Kessler, D. S. (2000). Mesendoderm
induction and reversal of left-right pattern by mouse Gdf1, a Vg1-related gene. Dev Biol
227, 495-509.
Wang, Q. T., Piotrowska, K., Ciemerych, M. A., Milenkovic, L., Scott, M. P., Davis,
R. W. and Zernicka-Goetz, M. (2004). A genome-wide study of gene activity reveals
developmental signaling pathways in the preimplantation mouse embryo. Dev Cell 6,
133-44.
151

Weinstein, D. C., Ruiz i Altaba, A., Chen, W. S., Hoodless, P., Prezioso, V. R.,
Jessell, T. M. and Darnell, J. E., Jr. (1994). The winged-helix transcription factor
HNF-3 beta is required for notochord development in the mouse embryo. Cell 78, 57588.
Wilson, P. A. and Hemmati-Brivanlou, A. (1995). Induction of epidermis and
inhibition of neural fate by Bmp-4. Nature 376, 331-3.
Wilson, P. A., Lagna, G., Suzuki, A. and Hemmati-Brivanlou, A. (1997).
Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal
transducer Smad1. Development 124, 3177-84.
Xu, R. H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P. and
Thomson, J. A. (2002). BMP4 initiates human embryonic stem cell differentiation to
trophoblast. Nat Biotechnol 20, 1261-4.
Xu, R. H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T. and Thomson, J. A. (2005).
Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of
human ES cells. Nat Methods 2, 185-90.
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi,
T., Nishida, E. and Matsumoto, K. (1995). Identification of a member of the
MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270,
2008-11.
Yamamoto, M., Meno, C., Sakai, Y., Shiratori, H., Mochida, K., Ikawa, Y., Saijoh,
Y. and Hamada, H. (2001). The transcription factor FoxH1 (FAST) mediates Nodal
signaling during anterior-posterior patterning and node formation in the mouse. Genes
Dev 15, 1242-56.
Yang, Y. P. and Klingensmith, J. (2006). Roles of organizer factors and BMP
antagonism in mammalian forebrain establishment. Dev Biol 296, 458-75.
Yeo, C. and Whitman, M. (2001). Nodal signals to Smads through Cripto-dependent
and Cripto-independent mechanisms. Mol Cell 7, 949-57.
Ying, Q. L., Nichols, J., Chambers, I. and Smith, A. (2003). BMP induction of Id
proteins suppresses differentiation and sustains embryonic stem cell self-renewal in
collaboration with STAT3. Cell 115, 281-92.
Yost, H. J. (2001). Establishment of left-right asymmetry. Int Rev Cytol 203, 357-81.
Zamparini, A. L., Watts, T., Gardner, C. E., Tomlinson, S. R., Johnston, G. I. and
Brickman, J. M. (2006). Hex acts with beta-catenin to regulate anteroposterior
patterning via a Groucho-related co-repressor and Nodal. Development 133, 3709-22.

152

Zeng, X., Miura, T., Luo, Y., Bhattacharya, B., Condie, B., Chen, J., Ginis, I.,
Lyons, I., Mejido, J., Puri, R. K. et al. (2004). Properties of pluripotent human
embryonic stem cells BG01 and BG02. Stem Cells 22, 292-312.
Ziomek, C. A. and Johnson, M. H. (1982). The roles of phenotype and position in
guiding the fate of 16-cell mouse blastomeres. Dev Biol 91, 440-7.

153

